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Abstract 
  
 The goal of this research is to investigate the role of K32 and K33 in the catalytic 
mechanism of R67 dihydrofolate reductase (DHFR).  K32 is located in the active site 
pore and is the only charged residue in the active site while K33 is located on the surface 
of R67 DHFR.  Both of the ligands for R67 DHFR, NADPH and dihydrofolate (DHF), 
have negative charges capable of forming ionic interactions with symmetry related K32 
residues.  NMR, DELPHI, and docking studies predict that K32 is involved in ionic 
interactions with the 2’phosphate of NADPH.  Docking studies also predict that K32 
participates in ionic interactions with DHF.  Mutagenesis of K32 in the R67 DHFR 
homotetramer results in the formation of an inactive dimer.  Thus, the role of K32 cannot 
directly be tested.  Therefore, the role of ionic interactions in ligand binding and catalysis 
was experimentally examined using salt effects on Kd1 (NADPH), total heat of binding for 
folate (qTotal), Km (NADPH), Km (DHF), kcat, kcat/Km (NADPH), and kcat/Km (DHF).  Salt sensitivities 
of these parameters indicate that ionic interactions are involved in binding both cofactor 
and substrate.  To examine the number of ionic contacts with each ligand, slopes of log-
log plots of various binding and kinetic parameters vs. ionic strength can be used.  
However, one of the requirements that must be met for the slope to be directly 
proportional to the number of ionic contacts involved in binding and catalysis is that 
different anions produce the same effect on the slopes of these plots.  Specific anion 
effects occur with R67 DHFR when salt sensitivities are compared in the presence of 
NaCl, NaF, or NaSCN.  This makes quantation of the number of ionic contacts between 
R67 DHFR and each ligand difficult.  In order to test the involvement of the 2’phosphate 
moiety of NADPH in ionic contacts, steady-state kinetics were performed using the 
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alternate cofactor NADH.  Significant effects were observed on kcat/Km (NADH) compared 
to kcat/Km (NADPH) revealing the 2' phosphate is most likely involved in an ionic interaction 
with R67 DHFR.   
Direct analysis of the role of K32 in binding and catalysis was examined using a 
quadruplicated gene construct of R67 DHFR containing one to two asymmetric K32M 
mutations.  One K32 mutation in each half pore of the enzyme results in a decrease in kcat 
but has minimal effects on Km values.  On the other hand, two K32 mutations in the same 
half pore result in significant effects on the Km values for NADPH and DHF as well as an 
enhancement of kcat.  The decrease in kcat observed with the K32M double asymmetric 
mutants that possess a single K32M substitution in each half-pore support that R67 
DHFR uses its symmetry to facilitate catalysis.  This may arise from increasing the 
number of species available to form the transition state.   
The increase in Km (NADPH) and Km (DHF) as well as the increase in kcat observed with 
the K32M mutant that possesses two substitutions in the same half pore supports that an 
ionic interaction(s) is lost to reach the transition state.  This mutant possesses 2 K32M 
substitutions in the same half pore (in the predicted binding site for DHF), resulting in a 
decrease in the affinity for DHF and NADPH in the ground state.  These data suggest that 
K32 is involved in ionic contacts with DHF in the ground state.  The unexpected 
elevation in Km (NADPH) however, may not reflect the true Kd (NADPH) for this mutant.  
Formation of the transition state is facilitated with this mutant.  One possible scenario 
consistent with an increase in kcat when two K32 residues are substituted in the same half 
pore involves the movement of DHF into a position that facilitates better overlap between 
v  
the nicotinamide ring of NADPH and the pteridine ring of DHF thus facilitating the 
chemistry.   
The salt sensitivities of the various binding and kinetic parameters, the large 
effects on kcat/Km in the presence of the alternate cofactor NADH, and the effects of the 
K32M double asymmetric mutants, reveal that K32 is most likely involved in at least one 
ionic contact with NADPH, and at least one ionic contact with DHF in the ground state.  
To allow formation of the transition state, one of these ionic interactions is lost.      
vi  
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Part I:  Introduction to R67 Dihydrofolate Reductase, a Functional and 
Structural Overview 
1  
General Introduction to Dihydrofolate Reductases 
 Dihydrofolate reductases (DHFRs) are ubiquitous enzymes that catalyze the 
NADPH dependent reduction of dihydrofolate (DHF) to tetrahydrofolate (THF).  THF is 
essential for the formation of thymidine, a precursor of the purine base thymine, purine 
nucleosides, methionine, and other metabolites (1). Thus, inhibition of DHFRs impairs 
both DNA and protein synthesis consequently resulting in cell death.  Due to their role in 
cell survival, these enzymes have been drug targets.  One clinically effective inhibitor of 
bacteria chromosomal DHFRs is the antibiotic trimethoprim (TMP).  However, R-
plasmid encoded DHFRs have been discovered to confer resistance to this antibiotic (2).  
R-plasmid Dihydrofolate Reductases   
To date, twelve groups of R-plasmid DHFRs have been discovered, namely types 
I-XII (2).  However, the type II R-plasmid encoded DHFRs confer the strongest 
resistance to TMP.  There are three type II R-plasmid DHFRs: R67, R388, and R751 (3-
5).  These R-plasmid DHFRs share greater than 78% amino acid sequence identity with 
differences occurring mainly at the amino terminus of these proteins (6).  However, 
removal of the first 17 amino acids in the amino terminus does not impair the activity of 
R67 DHFR, indicating they are not necessary for function (7).   
R67 DHFR is fascinating as it is structurally and genetically divergent from other 
known DHFRs (6, 8).  One possibility is R67 DHFR arose from an NADP-linked oxido-
reductase.  It is often compared to the chromosomal enzyme produced in E.coli, as it 
allows host E.coli to sustain life when the chromosomally encoded DHFR is inhibited.  
Although the chromosomally encoded enzyme is susceptible to inhibition at 
concentrations of trimethoprim around 1nm, R67 DHFR remains fully active.  In 
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addition, this enzyme is only weakly inhibited by methotrexate, which severely inhibits 
chromosomal DHFR (8, 9).  This indicates there must be significant differences in the 
structure as well as in the binding and catalytic properties of the R-plasmid encoded 
enzyme and the chromosomally encoded DHFR enzyme.   
Comparison of the Structures of R67 DHFR and E.coli Chromosomal DHFR 
Structure of R67 DHFR  
 R67 DHFR was first crystallized as a dimer (9); however, more recent 
crystallographic data (10), in combination with sedimentation equilibrium and molecular 
sieving studies (3, 11), reveal that this enzyme functions in vivo as a tetramer (12).  In 
1995, the tetramer crystal structure was solved to 1.7 Å resolution after chymotrypsin 
cleavage of the first 17 amino acids.  This structure reveals that each monomer consists of 
five antiparallel β–strands (labeled A-E) connected by short loops and a single 3-10 helix 
(10) (Figure 1).   Monomer 1 is made up of residues 1-78, monomer 2 by residues 101-
178, monomer 3 by residues 201-278, and monomer 4 by residues 301-378.   
The monomer-monomer interfaces of R67 DHFR are stabilized by an intersubunit 
β-barrel formed by the association of β-strands B, C, and D in adjacent subunits.  
Hydrophobic packing of sidechains within the intersubunit β-barrel, hydrogen bonding of 
anti-parallel β-sheets in symmetry related strands, and van der Waals interactions 
between methionine 26 (M26) residues in adjacent monomers also stabilize the 
monomer-monomer interfaces (10).   
The dimer-dimer interface of R67 DHFR is also stabilized by several bonding 
interactions.  These stabilizing forces include: tryptophan 38 (W38), 138, 238, and 338  
3  
Figure 1.  The α-carbon backbone of R67 DHFR.  R67 DHFR is a homotetramer with a 
single active site pore.  Each monomer is folded into 5 antiparallel β-sheets and a 310 
helix.  Monomer A is in green, monomer B is blue, monomer C is violet, and monomer D 
is purple.  The dimer-dimer interface is stabilized by hydrogen bonding between H62 
(red) and S59 (from a second subunit) as well as H62 imidazole stacking interactions 
between symmetry related partners (11, 13).  The mouth of the pore is 24 Å X 12 Å with 
a reduced diameter in the center of the pore.  This is due to an hourglass shape arising 
from symmetry related Q67 residues (yellow) which form the “floor and ceiling” of the 
active site creating an hourglass shaped pore (10). 
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stacking interactions; hydrogen bonding between glutamine 67 (Q67) residues in adjacent 
subunits; loop-loop interactions between residues in the loop connecting β-strands C and 
D (residues 60-65) and the four residues preceding strand B; hydrophobic stacking 
interactions between the imidazole ring of histidine 62 (H62) residues in symmetry 
related monomers; and, hydrogen bonding between the Nε2 of histidine 62 (H62) in one 
monomer and the γ-OH of serine 59 (S59) in a symmetry related adjacent monomer (10, 
11).  While all of these interactions are important for the stabilization of the dimer-dimer 
interface, pH titration and NMR chemical shift data demonstrate that the tetramer to two-
dimer equilibrium is pH dependent and that protonation of H62 results in the observed 
dissociation of the tetramer into two dimers (11).     
Crystallographic data also reveals that R67 DHFR possesses a single active site 
pore with 222 symmetry.  Residues from each of its four identical subunits make up the 
pore, including lysine 32 (K32), alanine 36 (A36), tyrosine 46 (Y46), threonine 51 (T51), 
glycine 64 (G64), serine 65 (S65), valine 66 (V66), glutamine 67 (Q67), isoleucine 68 
(I68), and tyrosine 69 (Y69) (10) (Figure 2).  S65, V66, Q67, I68, and Y69 make up 47% 
of the surface area of the active site (14).  The dimensions of the active site pore are 25 Å 
in length and 18 Å in width.  A total of 28 ordered water molecules are located in the 
pore, which has the shape of an “hourglass” (10).  This shape arises from symmetry 
related Q67 residues that create the “floor and ceiling” of the active site, producing a 
diameter in the center of the pore almost half the width at the mouth (10) (Figure 1).     
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Figure 2.  CPK surface of R67 DHFR illustrating residues lining the active site.  K32 is 
shown in yellow, Y46 is purple, S65 is orange, Q67 is lavender, I68 is blue, and Y69 is 
green (10, 14).
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Structure of E.coli Chromosomal DHFR   
 
Numerous crystallographic and NMR studies have been performed which 
illustrate that chromosomal DHFR is a monomeric protein with a molecular weight of 
18,000 daltons.  The structure of this monomer consists of 8 β-sheets connected by 4 α-
helices (15-17).  This enzyme possesses a single active site that contains a specific 
binding pocket for NADPH formed by β strands B (38-44) and E (90-95), and α-helices 
C (44-50) and F (97-104) as well as a hydrophobic binding site for DHF (L54, I50, and 
F31) with the exception of a single polar residue, aspartate 27 (D27).  Following cofactor 
and substrate binding, a conformational change occurs in the Met-20 loop (residues 9-
24), which connects the βA strand to the αB strand.  Residues 16-19 in this loop go from 
being disordered in the holoenzyme to a type I β-turn.  Ordering of this region of the 
Met-20 loop results in the “closed conformation” of the active site, thus solvent is 
excluded to create a hydrophobic environment for catalysis (18).         
Properties of NADPH and DHF 
 
 Commonly, the same ligands can be used for many different reactions that take 
place in the cell.  NADPH is an example of this, serving as a cofactor in many 
biosynthetic reactions.  It possesses a net charge of –3, arising from 2 regions of negative 
charge, a phosphate group at the 2’ position off the hydroxyl group of AMP and the 
pyrophosphate moiety linking the ribose of AMP to the ribose attached to the reactive 
part of the molecule, the nicotinamide ring (Figure 3).  The nicotinamide ring contains 
two reactive hydrogens on C4, a pro-R hydrogen below the plane of the ring and a pro-S 
hydrogen that is above the plane of the ring which participate in NADPH dependent 
hydride transfer reactions.  R67 DHFR transfers the pro-R hydrogen of NADPH.      
7  
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Figure 3.  Illustrations of ligands that bind in the active site pore of R67 DHFR.  (A) 
DHF is similar in structure to folate (depicted above) with the exception of a single bond 
between C7 and N8 in the pteridine ring.  DHF has a net negative charge of –2. (B) 
NADPH has a net negative charge of –3.  (C) Congo Red dye and (D) novabiocin 
effectively inhibit R67 DHFR activity (Ki = 2µM and 60µM) (unpublished results).     
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In addition, most enzymes can only use the β–epimer of NADPH for catalysis.  
Interestingly, R67 DHFR can use either the α or β-epimer of NADPH for catalysis. 
Although, the catalytic rate of R67 DHFR is higher in the presence of the β–epimer of 
NADPH.  This ability to utilize either epimer is uncommon (19).   
 DHF is present in the cell in a polyglutamylated form to prevent its passage 
through the membrane to the outside of the cell.  The monoglutamylated form of DHF is 
used for in vitro studies and is fully active, as it possesses the reactive pteridine ring.  
This molecule possesses a net charge of –2, which arises from the negatively charged 
carboxyl groups on the glutamate residue that forms the tail of DHF (Figure 3).  
Numerous studies indicate that before hydride transfer occurs DHF must be protonated at 
the N5 position to allow the C6 of the pteridine ring to accept the hydride from NADPH.  
Consistent with this finding, both Raman spectroscopy and H62C mutant studies indicate 
that R67 DHFR requires protonation of the N5 of DHF to facilitate catalysis (20, 21).   
Binding Mechanism for NADPH and DHF in the Active Site Pore of R67 DHFR   
Another unique feature of this enzyme is its binding mechanism.  Fitting of the 
electron density associated with bound folate is consistent with 2 folate molecules 
binding per tetramer, even though there are four potential binding sites (10).  However, 
the actual number of binding sites available is dictated by ligand cooperativity.  This is 
illustrated by isothermal titration calorimetry (ITC) and fluorescence anisotropy studies, 
which indicate that 2 NADPH, 2 DHF, or 1NADPH and 1 DHF molecule can bind in the 
active site pore of R67 DHFR (22).  The latter forms the productive ternary complex.  
NADPH displays negative cooperativity between the first and second binding events with 
macroscopic Kds of 2.5 and 95 µM.  The negative cooperativity most likely results from 
9  
steric repulsion.  Binding between DHF molecules is positively cooperative, Kd1=125 µM 
and Kd2=8.8 µM (Figure 4).  Further, a stoichiometry of 1 is observed upon titrating 
folate into a 1:1 mixture of R67 DHFR:NADPH indicating 1 folate molecule binds to 
form the ternary complex and displays positive cooperativity (22).   
ITC, fluorescence anisotropy, and structural data indicate the active site pore of 
R67 DHFR can only accommodate 2 ligands simultaneously (10, 22).  To achieve 
preferential formation of the active ternary complex, this enzyme uses various methods: 
numerous non-covalent interactions to tightly bind NADPH, negative cooperativity 
between 2 NADPH molecules, positive cooperativity between 2 DHF molecules, and 
positive cooperativity between bound NADPH and DHF.  Using this binding data, a 
strategy may be devised that R67 DHFR uses to form the active ternary complex.  The 
enzyme utilizes the 222 symmetry of its active site pore to facilitate NADPH binding, as 
it has four potential binding sites.  NADPH binds near the center of the active site, 
resulting in the loss of symmetry.  This limits the number of sites and orientations 
available for DHF binding and thereby facilitates formation of the active ternary 
complex.  This binding scenario arises from condensation of the various Kd values and 
proposes NADPH binds first, followed by DHF, indicating that binding of ligands in the 
active site pore of R67 DHFR does not follow a random addition pattern (22).      
Inhibitor Binding to R67 DHFR 
 Another interesting aspect of R67 DHFR is how it is able to avoid enzymatic 
inhibition by the folate analogs trimethoprim (TMP) and methotrexate (MTX), which 
severely inhibit bacterial and vertebrate DHFRs (5).  Comparison of crystal structures of 
MTX and TMP bound to chromosomal DHFR to the crystal structure of R67  
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Figure 4.  Binding scheme for R67 DHFR determined by ITC (22).  This schematic 
reveals that the ligands prefer to bind in a non-random fashion where NADPH binding 
occurs first in the active site pore followed by DHF.  Formation of non-productive 
complexes leads to inhibition of enzyme activity as observed in various mutants (14, 20, 
23).   
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DHFR•folate lends insight into how R67 DHFR avoids inhibition (10, 18).  Both of these 
compounds contain an amino group substitution at the C4 of the pteridine ring (MTX) or 
the pyrimidine ring (TMP).  Crystallography data has shown that these compounds bind 
very tightly to the chromosomal enzyme because its active site is such that it allows the 
formation of hydrogen bonds between backbone carbonyl oxygens of A97 and L4 and the 
amino group located at C4 of MTX and TMP (18).  In addition, the amino group 
substituent at C4 favors protonation at N1 in the pteridine ring of MTX and the 
pyrimidine ring of TMP.  This proton at N1 is involved in a hydrogen bond with a nearby 
carboxylate group (D27) in the active site of the chromosomal enzyme.  Conversely, the 
backbone amide group of I68 in R67 DHFR appears positioned so that it causes steric 
repulsion with the amine group at the C4 position on the pyrimidine ring of both TMP 
and pteridine ring of MTX.  Additionally, the active site of R67 DHFR lacks atoms in the 
correct orientation to hydrogen bond with the amino group at C4 and a carboxyl group in 
the correct orientation to interact with the proton at N1 in the pteridine ring of MTX and 
the pyrimidine ring of TMP (10).   
 These results illustrate how R67 DHFR avoids inhibition by these clinical 
compounds.  A major question remains: what will inhibit the activity of this enzyme?  
Kinetic studies with Congo Red dye and novobiocin illustrate these are effective 
competitive inhibitors of R67 DHFR (unpublished results) (Figure 3).  While these 
compounds are not themselves useful in a clinical sense, they might be helpful in the 
design of an inhibitor that possesses some of the structural characteristics of these 
molecules.  Currently, ITC and inhibition kinetics are being performed to identify the 
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importance of the various moieties of DHF and NADPH, which could potentially be used 
in the design of an effective inhibitor for R67 DHFR (Jackson, Ph.D. project). 
Comparison of Catalytic Mechanism of R67 DHFR to E.coli Chromosomal DHFR   
Proton Donor in Active Site   
Previously conducted studies indicate the N5 of the pteridine ring of DHF must be 
protonated before C6 can accept a hydride from NADPH (24-27).  The solution pKa of 
DHF is 2.59.  E.coli DHFR elevates the pKa of DHF to ~6.5 (28).  Thus, the increase in 
the pKa of bound DHF by E.coli DHFR facilitates protonation of DHF.  One model for 
catalysis involves aspartate 27 (D27) serving as a catalytic acid by protonating the N5 of 
the pteridine ring of DHF leading to high catalytic efficiency (24, 29, 30). Still debated is 
the issue of whether D27 directly protonates the N5 of the pteridine ring of DHF or uses 
an intermediary water (18, 24, 31).   
In contrast, the pKa of DHF when in complex with R67 DHFR is less than 4, 
consistent with no to minimal elevation of the pKa of DHF when in complex with R67 
DHFR (21, 29, 32).  The pH-rate profile of R67 DHFR is bell-shaped with a maximum 
occurring around pH 6.  This acidic pKa corresponds to a protein concentration dependent 
loss of activity as the active tetramer dissociates into relatively inactive dimers (33).  pH 
profiles using the disulfide-linked tetramer H62C, to prevent dissociation of the tetramer, 
indicates that there is a linear increase in kcat with decreasing pH.   The increase in kcat 
with decreasing pH suggests that the enzyme uses pre-protonated DHF as a substrate for 
its hydride transfer reaction (33). The absence of an inflection point in the pH-rate profile 
of this mutant, as well as structural data of the active site, indicate R67 DHFR lacks a 
proton donor in the active site.   
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Raman difference spectroscopy has also been used to analyze if R67 DHFR 
possesses a proton donor in the active site.  Using Raman spectroscopy, the N5=C6 
stretch frequency has been measured for various dihydropterin-enzyme complexes.  The 
frequency of this bond is 1655 cm –1 when DHF is in buffer, pH 7.  The pKa of DHF in 
solution is 2.59;therefore, this frequency corresponds to the unprotonated form of DHF.  
Protonation of the N5 of the pteridine ring results in a frequency of 1675 cm-1 while 
deuteration of N5 shifts the frequency of the N5-C6 bond to 1660 cm-1.  These 
parameters were used to analyze the protonation state of DHF in the R67 DHFR reaction 
(21).  When the Raman spectra for the R67 DHFR• NADP+ (pH 7) complex is subtracted 
from the R67 DHFR•NADP+•DHF spectra (pH 7) for samples in water or D20, no 
deuterium shift is observed for the N5=C6 stretch mode.  The peak in the difference 
raman spectra occurs at a similar frequency to that of DHF in buffer, pH 7.  Thus, the 
absence of a deuterium shift indicates DHF is unprotonated in this ternary complex (21).   
The pH-rate profile of the H62C mutant, Raman spectroscopy, and X-ray 
structure of R67 DHFR are consistent with the absence of a proton donor in the active 
site (21, 33). Surrounding solvent must therefore donate a proton to the N5 of DHF to 
facilitate catalysis (21).  
Active Site and Catalysis   
R67 DHFR lacks a specific binding pocket characteristic of efficient enzymes.  
Instead, it possesses a solvent exposed active site pore and lacks active site residues that 
penetrate deep into the pore (10).  In contrast, chromosomal DHFR utilizes residues in 
the active site to form a binding pocket in which substrate and cofactor are differentially 
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bound and creates a hydrophobic environment for hydride transfer.  Typical distances for 
hydride transfer are between 2.6-2.75 Å (34).  Both the hydrophobic binding pocket and 
the presence of a proton donor in the active site allow the chemistry of E.coli 
chromosomal DHFR to be carried out at a much faster rate than R67 DHFR allowing it a 
higher catalytically efficiency at pH 7: chromosomal DHFR has a hydride transfer rate of 
238 s-1 (35) vs. 1.3 s-1 for R67 DHFR (7).  This is also reflected by the difference in the 
rate-limiting steps between these enzymes, product release for chromosomal vs. hydride 
transfer for R67 DHFR (7, 36).   
R67 DHFR utilizes a different catalytic strategy than chromosomal DHFR.  A set 
of core residues not only form the active site and make contacts with the ligands but also 
generate a binding site that possesses the potential for overlapping binding sites.  This 
maximizes interligand contacts.  This has previously been called “hot spot binding”(14, 
37).  For this enzyme to carry out catalysis, interligand contacts are crucial since the 
active site residues possess dual roles in binding both NADPH and DHF.  This 
hypothesis is supported by kinetic characterization of proteins possessing mutations in 
the active site, which effect binding of both NADPH and DHF equally.  In addition, the 
cooperativity patterns between the various ligands suggest interligand interactions are 
highly important (14).  From these studies, it appears that R67 DHFR is a primitive yet 
important enzyme, as it provides a survival mechanism for its host E.coli in the presence 
of trimethoprim. 
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Insight into the Catalytic Mechanism of R67 DHFR  
Conformation of NADPH and DHF in the Active Site  
Measurements of intraligand nuclear Overhauser effects (NOEs) in NADPH 
indicate that there are few interactions between the different moieties of NADPH (38).  In 
addition, this NMR data indicates that the conformation of the nicotinamide ring is syn 
with respect to its ribose ring due to NOEs between protons in each moiety (39).  Few 
NOEs occurred between the atoms in DHF as well.  Lack of extensive NOEs between the 
atoms in each molecule suggests that NADPH and DHF are bound in extended 
conformations in the active site.   
Ligand-Ligand Interactions between NADPH and DHF    
Interligand nuclear Overhauser effects (ILNOEs) were examined using the ternary 
complex R67 DHFR•NADP+•folate incubated in the presence of D2O.  Interatomic 
distances were measured from 2-D NOESY spectra generated by cross-peaks between the 
protons of folate and NADPH (38).  These measurements reveal that interligand 
interactions occur between the nicotinamide ring of NADP+ and the pteridine ring of 
folate, with less than 4Å between them.  A model for ligand binding in the active site of 
R67 DHFR can be generated using this data, in which there is overlap of the pteridine 
ring of folate and the nicotinamide ring of NADPH (38, 39).  Lack of ILNOEs between 
the tails of NADPH and folate suggest that these ligands enter the pore from opposite 
ends and meet in the middle.  
Stereochemistry of Hydride Transfer   
Additional information about ligand conformation in the active site of R67 DHFR 
comes from NMR studies examining the stereochemistry of hydride transfer (40).  
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Labeled NADPH containing a pro-S deuterium and a pro-R hydrogen at the C4 of the 
nicotinamide ring was incubated with DHF and R67 DHFR.  Following incubation, 
oxidized NADP+ was isolated using chromatography.  1H NMR spectroscopy of the 
labeled, reacted NADP+ was compared to commercially available NADP+.  The spectra 
revealed that a pro-S deuterium remained at the C4 position of the reacted NADP+ 
indicating that the pro-R hydrogen had been transferred to DHF (40).  R67 DHFR, like 
chromosomal DHFR, transfers the pro-R hydrogen of NADPH to DHF.  From the x-ray 
structure of folate bound to R67 DHFR, the pteridine ring of folate (Fol I, the 
productively bound folate in the pore) is positioned in the center of the pore with its si 
face accessible to receive the hydride from NADPH thus allowing catalysis to occur (10).  
Specifically, C6 of the si face of the pteridine ring of folate accepts the pro-R hydrogen 
from NADPH.  
NMR model for the Transition State of R67 DHFR   
The combination of NOEs due to the intraligand interactions, ILNOEs identifying 
interactions between DHF and NADPH, and isotope experiments describing the 
stereochemistry of hydride transfer, is consistent with the substrate and cofactor adopting 
an endo conformation in the transition state for R67 DHFR (38, 39).  Quantum 
mechanical calculations have been performed which predict the endo conformation is 
favored by 2-8 kcal/mol over the exo conformation for the DHFR reaction (31, 41).   
In the endo conformation there is extensive overlap of the molecular orbitals of 
the donor and acceptor atoms in the nicotinamide and pteridine rings (C4 of NADPH and 
C6 of DHF).  This is achieved by partial stacking between the nicotinamide and pteridine 
ring systems (34).  The exo conformation results from hydride transfer in which there is 
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little overlap between the molecular orbitals of the donor and acceptor atoms (42).  Thus, 
the exo transition state can be described as a conformation in which the nicotinamide ring 
approaching the pteridine ring at an angle such that the hydride ion is adjacent to the 
accepting C6 atom of the pteridine ring while there is no contact between the rings 
(Figure 5).       
Computational Predictions of Ligand Binding and the Active Ternary Complex  
Further insight into the conformation of the ligands in the active site was gained 
from computational studies of R67 DHFR using DOCK 4.0, which scores conformational 
predictions based on van der Waals distances (43).  This type of analysis led to 
predictions of NADPH binding in the active site of R67 DHFR.  First, the NMN moiety 
of NADPH was docked into the R67 DHFR• FolI complex (43).  The position of the 
pteridine ring of folate in the active site comes from fitting of the electron density of 
bound folate in the crystal structure of R67 DHFR.  While the structure has 2 folates 
bound in the active site, FolI was used for the docking studies, as it is the productively 
bound folate (i.e. has its si face in position to accept a hydride whereas FolII has its face 
towards the side of the pore and would be unable to accept a hydride) (10).  Eight out of 
the top ten docked NMN conformers docked into the active site in an orientation 
consistent with previous experimental data: a) NMN had a syn geometry with respect to 
the ribose and nicotinamide ring (39). b) NMN was in an orientation compatible with 
pro-R hydride transfer (40). c) NMN docked in a conformation such that if the tail of 
NADPH were added it would be on the opposite side of the pore as the glutamate tail of  
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Figure 5.  Endo versus exo transition state models.  R67 DHFR is proposed to use the 
endo transition state for catalysis as it is predicted to be more favorable by 2-8 kcal/mol 
over the exo transition state (41).  The nicotinamide ring is indicated in yellow in the 
endo transition state and in purple in the exo transition state.  The pteridine ring is shown 
with carbon in green, nitrogen in blue, hydrogens in white, and oxygen in red.  In the 
endo conformation there is maximal overlap of the groups involved in hydride transfer, 
C4 of the nicotinamide ring and C6 of the pteridine ring, due to ring stacking.  In the exo 
conformation, the nicotinamide ring approaches the pteridine ring at an angle, resulting in 
almost no overlap between the rings (43).   
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folate.  This agrees with ILNOE data that suggests the ligands bind in an extended 
orientation with no overlap of the tails (38, 39). d) The transition state adopted by the 
R67 DHFR •Folate•NMN docked complex is consistent with an endo conformation, 
which has been suggested to be more stable than the exo conformation (31, 41).  
A similar series of experiments were carried out to predict the orientation of DHF 
within the active site using the top-scoring NMN candidate from the  
R67 DHFR•NMN•FolI complex (43).  Twenty-one out of twenty-five of the top scoring 
conformers placed the pteridine ring of DHF in the same orientation as the pteridine ring 
of FolI (the productively bound folate) in the crystal structure of R67 DHFR (43).  
Variation was observed in the dockings of DHF with respect to the PABA-Glu tail (para- 
aminobenzoic acid).  Multiple orientations of the tail of DHF predicted by DOCK agree 
with the disorder observed for this moiety in the crystal structure with R67 DHFR as well 
as with NMR data that indicate the glutamate tail of DHF tumbles in solution (10, 38). 
Finally, NADPH was docked into the active site using the R67 DHFR•FolI 
complex.  The conformer most consistent with previous experimental data ranked 33 out 
of the top 100.  This conformer of NADPH possesses a syn geometry for the carboxamide 
and ribose ring and an anti conformation about the adenine and ribose rings (38-40, 43).  
Due to the low ranking of the NADPH docked structure as well as it being the only 
conformer in the orientation consistent with experimental data, there is less confidence in 
its docked orientation.  The results of these computational studies indicate that the ligands 
of R67 DHFR bind in an overall extended conformation and possess flexibility with 
respect to the glutamate tail of DHF (10, 38, 43).  Together, NMR and docking studies 
support the hypothesis that R67 DHFR uses an endo transition state to accomplish 
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hydride transfer of the pro-R hydrogen of NADPH to C6 on the si face of the pteridine 
ring on DHF (10, 38-40, 43).   
Active Site Residues and Their Role in Ligand Binding 
 R67 DHFR is interesting as it has a single active site pore made up by four 
subunits.  Residues that line the pore in each monomer are K32, Y46, T51, S65, V66, 
Q67, I68, and Y69 (Figure 2).  A combination of structural, NMR, docking, and site-
directed mutagenesis studies has proved invaluable for assessing the role of these 
residues in binding and catalysis (10, 14, 43, 44) (Narayana, personal communication).  
Although some structural data exists, it is only with folate.  Folate is similar in structure 
to DHF with the exception of a double bond between C7 and N8.  Hence, the data 
directly observed for folate binding can likely be applied to DHF binding.  While an x-
ray structure for NADPH binding has not been obtained, several studies have been 
conducted to predict a binding mode that leads to an active ternary complex with DHF in 
the active site of R67 DHFR (38, 43, 44) (Narayana, personal communication).   
In the crystal structure, K32 is not observed to directly bind to folate.  However, 
the electron density for the para-aminobenzoic acid glutamate tail is such that the 
positions of these moieties could not be observed (10).  Yet, it is predicted by docking 
studies to be involved in an ionic interaction with the glutamate carboxylate groups on 
the tail of DHF (43).  It is also hypothesized to be involved in ionic interactions with the 
2’ phosphate off the hydroxyl of the AMP ribose as well as with the pyrophosphate 
bridge of NADPH (10, 43, 44) (Narayana, personal communication).   These predictions 
however, will be tested experimentally. 
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Mutagenesis and kinetic characterization of Y46 (Y46F) and S65 (S65A) indicate 
these residues are not crucial for binding either NADPH or folate (14).  Accordingly, an 
interaction between these residues and folate was not observed in the crystal structure.  
However, indirect interactions between the hydroxyl groups of these residues and folate 
through intermediary water molecules are possible (43).   
V66 is involved in a hydrogen bond with the N8 of folate through an intermediary 
water (10).  It is predicted to form hydrogen bonds with the N5 and N6 atoms of the 
pteridine ring of NADPH through its backbone oxygen (43). 
Four symmetry related Q67 residues line the pore forming a “ceiling” and a 
“floor”.  Crystal structure data reveal this residue is involved in van der Waals 
interactions with the pteridine ring of folate (10).  Q67 is predicted to form van der Waals 
interactions with the nicotinamide ring of NADPH as well as a hydrogen bond with the 
ribose hydroxyl of NADPH at the O2’ position (43).  Mutation of this residue leads to 
severe cofactor and substrate inhibition due to ready formation of the 2 NADPH and 2 
DHF non-productive complexes.  Thus, this residue is also involved in establishing the 
cooperativity of ligand binding (23, 45).   
I68 is involved in a hydrogen bond through its backbone amide to the 4-oxo group 
of folate as well as with the N8 of folate through an ordered water molecule in the active 
site (water 124) (10).  In agreement with the structural data, mutagenesis of this residue 
to either methionine or leucine results in approximately a 4-fold or 8-fold decrease in the 
binding affinity for DHF (14).  I68 is predicted to be involved in a hydrogen bond with 
the carboxamide group of the nicotinamide ring.  In agreement with these predictions, 
mutagenesis of this residue results in an 8-fold increase in the Km (NADPH) (14, 43).   
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A direct interaction between Y69 and folate is not observed in the crystal 
structure.  Yet, it may form a hydrogen bond with the tail of folate through an 
intermediary water.  Y69 is predicted to be involved in a hydrogen bond (through a water 
molecule) to an oxygen off the pyrophosphate bridge of NADPH.  It is also predicted to 
be involved in van der Waals interactions using its CD1 and CE1 atoms with the ribose 
hydroxyl groups (43).  Kinetic studies with the Y69F mutant, which results in the 
removal of hydrogen bonding potential, results in a 12-fold decrease in  
Km (NADPH) (14) (Stinnett, unpublished results).  
Kinetic characterization of R67 DHFRs that possess mutations of residues, which 
reside in the active site, reveal that binding of both NADPH and DHF are effected 
equally.  Therefore, it appears this enzyme uses its symmetry for binding either ligand in 
related sites (14, 23)(Hicks, unpublished results). 
Electrostatics and R67 DHFR Binding/Catalytic Mechanism 
Electrostatics have been illustrated to be crucial for many different aspects of 
protein folding/structure and enzymatic processes.  Charge-charge interactions have been 
implicated in providing protein stability in halophiles, as well as mesophiles (46).  Yet, 
charge-charge interactions can also be destabilizing as the energetic cost of desolvation 
may exceed the enthalpic contribution of these interactions.  This is observed in Bruce 
Tidor’s work using computational approaches to predict energetic values of salt bridges 
in proteins (47-49).  Electrostatics have also been demonstrated to be important in 
attracting ligands to the active site.  DELPHI, a finite Poisson-Boltzmann difference 
solver, is commonly used to predict electrostatic potentials of enzymes (50).  This 
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computational algorithm predicts that R67 DHFR possesses a positive electrostatic 
potential at the active site generated by lysine 32 (K32) and lysine 33 (K33) (43) 
(Figure 6).  Mutagenesis of these residues using the computer program INSIGHT, results 
in a loss of the positive electrostatic potential at the active site.  K32, which is located  
closer to the active site than K33, however seems to play a more significant role in 
generating the potential.  This is apparent from the drastic reduction in the positive 
electrostatic potential at the active site that results from computational mutagenesis of 
K32 to methionine (43).   
Positive electrostatic potentials have been predicted to be utilized by several 
DHFRs to attract the negatively charged ligands NADPH (-3) and DHF (-2) to the active 
site.  This includes, E.coli, S.faecium, L.casei, Mus musculus, human, and bovine DHFRs 
(51).  Enzymes other than DHFRs have also been predicted to utilize electrostatic 
potentials to influence ligand binding such as superoxide dismutase, barnase, and 
acetylcholine esterase (50, 52).  
A common technique employed to analyze the role of electrostatics in ligand 
binding and catalysis is salt effects.  Salt sensitivity of kinetic and thermodynamic 
parameters is indicative that ionic interactions are involved in these processes.  Ionic 
interactions are the strongest electrostatic interactions.  This is reflected by a distance 
dependence of 1/r compared to a distance dependence of 1/r3 for charge-dipole 
interactions and 1/r6 for dipole-dipole interactions (53).  Not only can the involvement of 
ionic interactions in ligand binding be studied, the number of ionic interactions involved 
can be quantitated.   This was first reported in 1976 by Record et al, and more recently in 
2001 by Park and Raines (54, 55).  In 1976, Record et al described several studies of the 
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Figure 6.  DELPHI predictions of the electrostatic potential of R67 DHFR.  (A).  
DELPHI predicts that R67 DHFR possesses a positive electrostatic potential at the active 
site generated by K32 and K33.  Regions of negative electrostatic potential are depicted 
in red, neutral in white, and positive electrostatic potential in blue.  The units for the 
electrostatic potential are kT.  (B).  Computational mutagenesis of K33 results in a minor 
decrease in positive electrostatic potential at the pore.  (C).  Computational mutagenesis 
of K32 results in a significant decrease in the positive electrostatic potential. (D).  
Mutagenesis of both K32 and K33 results in a negative electrostatic potential on the 
surface of R67 DHFR (43). 
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salt sensitivity of oligonucleotide and DNA binding to ribonuclease A (RNase A).  The 
Kd values for both DNA and oligonucleotide binding increased with increasing salt 
concentration.  This illustrated that the charged moieties of these molecules, the 
negatively charged phosphates, were involved in ionic interactions with cationic residues 
in RNase A.  In fact, a linear correlation was observed for the logarithm of the Kd vs. the 
logarithm of the salt concentration.  This demonstrates there is a relationship between salt 
concentration and ligand binding affinity.  The slope of this log-log plot is linearly 
proportional to the number of ionic interactions involved in binding, i.e. the number of 
ionic interactions between RNase A and the phosphates in DNA (54).   
Recently, Park and Raines described the application of salt effects to enzyme 
catalysis using RNase A as a model system (55).  These studies monitored 
oligonucleotide binding to wild-type (wt) RNase A as well as the RNase A mutants 
K7A/R10A/K66A and K41R.  A linear correlation was observed for log-log plots of 
kcat/Km of wt and mutant RNase A vs. salt concentration illustrating the salt dependence 
of this kinetic parameter.  The slopes of these log-log plots are ascribed to the number of 
ionic interactions involved in binding phosphate groups of the oligonucleotide.  Slopes of 
the log-log plots quantifying the number of ionic interactions involved in phosphate 
binding are consistent with the X-ray structure of ribonuclease A bound to the 
oligonucleotide d(ApTpApApG) identifying the phosphate binding sites (55).   
This type of interpretation is similar to that of the slopes of pH-rate profiles.  The 
typical acid-base catalyst possesses a bell shaped pH-rate profile.  This shape is produced 
by an inflection point at a pH where the maximal kcat/Km occurs followed by a linear 
decline in kcat/Km with increasing and decreasing pH.   The slopes of the linear portion of 
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log kcat/Km vs. log pH plots are equal to the number of titratable groups involved in 
catalysis (55).  Similarly, the slopes of log-log plots of Kd or kcat/Km vs. ionic strength are 
equal to the number of ionic interactions involved in binding.  Salt studies have also 
proved useful for the elucidation of the binding mechanism of a number of other proteins 
including NS3 hepatitis C protease, cytochrome P450 reductase, vitronectin, Syk Kinase, 
and antithrombin (56-60).  This approach is also being used to investigate the number of 
ionic interactions involved in binding and catalysis for R67 DHFR.   
While this type of analysis can be very insightful, there are several criteria that 
must be met to obtain meaningful results 1) The salt concentration of the buffer should 
not significantly affect the structure of the enzyme.  2) Salt should not significantly affect 
the pKa of the substrates and thereby produce an artificial effect on binding/catalysis.  3) 
Alternative anions should result in the same slope of log-log plots of kinetic parameters 
vs. ionic strength.  4) The rate-limiting step should be the chemistry step of the reaction.  
5) Slopes of log-log plots of Kd vs. ionic strength should agree with log-log plots of the 
kinetic parameters (55).         
Charged Residues in R67 DHFR 
 Only two charged residues occur near the active site of R67 DHFR, K32 and K33.  
In addition to their predicted role in generating a positive electrostatic potential at the 
active site or R67 DHFR, docking and NMR data suggest K32 is involved in an ionic 
interaction with the 2’phophate off the hydroxyl of the AMP ribose ring as well as with 
the pyrophosphate bridge of NADPH (43, 44) (Narayana, personal communication).  
Early predictions of the involvement of this residue in binding NADPH led to 
experiments to test its role.  Mutation of K32 to the non-polar amino acid alanine was 
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deleterious to the quaternary structure of R67 DHFR, resulting in an inactive dimer 
(Hamilton, masters thesis) as demonstrated using both molecular sieving and pH titration 
experiments.  Kinetic characterization of the dimeric form of K32A proved difficult, but 
revealed that in addition to the structural effects of this mutant, there is a significant 
decrease in the kinetic parameters of the K32A mutant compared to other dimeric 
mutants, H62C (reduced) (33) and W38F R67 DHFR (61).         
 K33 is located on the surface of the enzyme and in addition to its predicted role in 
generating a positive electrostatic potential at the active site of R67 DHFR, it may also 
facilitate cofactor and substrate binding directly or by positioning K32 in the proper 
orientation to make ionic contacts with the ligands. 
Quadruplication of R67 DHFR to Examine Asymmetric Mutations 
  Four gene copies of R67 DHFR have been linked in frame (23, 45) to introduce 
asymmetry into the active site of R67 DHFR.  This will allow examination of the effects 
of mutations in individual domains to analyze specificity of interactions as well as the 
role of interligand cooperativity.  Originally, this protein was constructed without unique 
restriction sites between gene copies.  This resulted in the inability to specifically mutate 
individual domains of R67 DHFR (45).  To circumvent this problem, a new 
quadruplicated gene of R67 DHFR was generated (23).  This molecule possesses unique 
restriction enzyme sites engineered between the gene copies to allow for mutagenesis of 
an individual gene copy and ligation back into the construct.  In this way, mutations can 
be generated asymmetrically in R67 DHFR.   
The protein product of this construct, Quad2, is four times the molecular mass of 
monomeric R67 DHFR and is quite active, possessing kcat and Km values similar to those 
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of wt R67 DHFR.  A seventeen amino acid linker sequence corresponding to the native 
amino terminus has been used to tether the gene copies of R67 DHFR resulting in a 
protein product that consists of domains tethered together where each domain 
corresponds to a monomer in wt R67 DHFR.  However, one concern with this 
quadruplicated gene product was topology switching.  The linker sequence tethering 
domains 2 and 3 is long enough to allow the formation of an alternative conformation 
where domain 2 is adjacent to domain 4.  In this case, it would be impossible to study 
effects of asymmetric mutants since the orientation of domains 3 and 4 would be 
unknown.   
Using crystal structure data which indicates that H62 pairs with S65 at the dimer-
dimer interface of R67 DHFR, complementation experiments were performed by Dam et 
al. with S65A mutants that form inactive dimers and H62L mutants that form inactive 
dimers.  Mixing S65A dimeric mutants and H62L dimeric mutants results in the 
formation of an active R67 DHFR hetero-tetramer (13).  This strategy was used with the 
four-gene copy construct of R67 DHFR that was linked in frame to produce a tethered 
protein, Quad3, which lacked the ability to undergo topology switching.  This protein 
thus contained an H62L mutation in gene copy 4 and an S59A mutation in gene copy 1.  
Flip-flopping of domains 3 and 4 would result in the pairing of a hydrophobic residue 
with a polar residue, which is unfavorable.  Thus, this is a useful system for studying the 
effects of asymmetric mutations on ligand binding, catalysis, and cooperativity. 
Focus of Research Studies 
While some insight into the catalytic mechanism of R67 DHFR has been gained, 
there are still many unanswered questions.  The focus of this dissertation is to investigate 
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the role of ionic interactions in ligand binding and catalysis of R67 DHFR.  NMR and 
docking predictions of the involvement of K32 in ionic interactions led the way for 
experimental testing of this hypothesis.  To evaluate the importance of ionic interactions 
in binding/catalysis, salt effects on K33M and wt R67 DHFRs were examined since 
mutagenesis of K32 in the R67 DHFR homotetramer results in the formation of inactive 
dimers.  The role of the charged moieties of NADPH, the phosphate at the 2’ position off 
the AMP ribose and the pyrophosphate bridge, in ionic interactions with R67 DHFR have 
also been evaluated.  Generation of a four-gene copy construct of R67 DHFR, which is 
linked in frame, provided an opportunity to directly test the hypothesis that K32 is 
involved in ionic interactions with the ligands.  From these studies, several discoveries 
have been made describing (1) a role for ionic interactions involved in ligand binding and 
catalysis, (2) the contribution of the 2’phosphate vs. the pyrophosphate bridge of NADPH 
and the glutamate moiety of the PABA-Glu tail of DHF, (3) the importance of the 
symmetry of the R67 DHFR active site for ionic interactions, and (4) the involvement of 
K32 in ionic interactions in R67 DHFR.        
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Part II:  Role of Ionic Interactions in Ligand Binding and Catalysis of 
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sequence.  This enzyme is a homotetramer, when a single residue is mentioned; all four 
related residues are implied.      
Abstract 
R67 dihydrofolate reductase (DHFR), which catalyzes the NADPH dependent 
reduction of dihydrofolate to tetrahydrofolate, belongs to a type II family of R-plasmid 
encoded DHFRs that confer resistance to the antibacterial drug, trimethoprim. Crystal 
structure data reveals this enzyme is a homotetramer that possesses a single active site 
pore.  Only two charged residues in each monomer are located near the pore, K32 and 
K33.  Site-directed mutants were constructed to probe the role of these residues in ligand 
binding and/or catalysis.  As a result of the 222 symmetry of this enzyme, mutagenesis of 
one residue results in modification at four related sites.  All mutants at K32 affected the 
quaternary structure, producing an inactive dimer.  The K33M mutant shows only a 2-4 
fold effect on Km values.  Salt effects on ligand binding and catalysis for K33M and 
wildtype R67 DHFRs were investigated to determine if these lysines are involved in 
forming ionic interactions with the negatively charged substrates, dihydrofolate (overall 
charge of -2) and NADPH (overall charge of -3).  Binding studies indicate two ionic 
interactions occur between NADPH and R67 DHFR.  In contrast, binding of folate, a 
poor substrate, to R67 DHFR•NADPH appears weak, as a titration in enthalpy is lost at 
low ionic strength.   Steady state kinetic studies for both wild type (wt) and K33M R67 
DHFRs also support a strong electrostatic interaction between NADPH and the enzyme.  
Interestingly, quantitation of the observed salt effects by measuring the slopes of the log 
ionic strength vs. the log kcat/Km plots indicates only one ionic interaction is involved in 
forming the transition state.  These data support a model where two ionic interactions are 
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formed between NADPH and symmetry related K32 residues in the ground state.  To 
reach the transition state, an ionic interaction between K32 and the pyrophosphate bridge 
is broken.  This unusual scenario likely arises from the constraints imposed by the 222 
symmetry of the enzyme. 
Introduction 
 Dihydrofolate reductases (DHFRs) are ubiquitous enzymes that catalyze the 
NADPH dependent reduction of 5,6-dihydrofolate (DHF) to form 5,6,7,8-tetrahydrofolate 
(THF). The formation of THF is important since it is a precursor for purine nucleosides, 
methionine, and many other metabolites (1).  Thus, inhibition of this enzyme results in 
disruption of DNA synthesis and consequently cell death.  Trimethoprim (TMP) is a 
clinically important inhibitor of bacterial DHFRs.  However, R67 DHFR, a type II R-
plasmid encoded DHFR, confers resistance to TMP upon its hosts.  This enzyme has no 
sequence or structural homology to other known DHFRs.   Therefore, to gain more 
insight into the catalytic mechanism of this enzyme, the role of ionic interactions in 
ligand binding and catalysis was investigated. 
 The crystal structure of R67 DHFR was previously solved by Narayana et al., (2).  
Each monomer is a five stranded β–barrel consisting of 78 amino acids that self-associate 
to form the active tetramer.  R67 DHFR contains a single active site pore formed from 
each of the four identical subunits (Figure 1).  This pore possesses 222 symmetry and 
contains four possible binding sites.  Due to steric constraints, the pore can only 
accommodate two ligands simultaneously.  Two folate molecules were observed by time 
resolved fluorescence anisotropy and isothermal titration calorimetry (ITC) data to bind 
in the pore.  ITC also revealed that only two NADPH molecules bind in the pore (3).  The  
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Figure 1.  The active homotetrameric form of R67 DHFR is formed by the self-
association of four identical subunits, A (blue), B (green), C (magenta), and D (red).  K32 
and K33 residues are shown in CPK format and one set of the symmetry related residues 
are labeled at the lower right.  The side chain of K32 projects into the active site pore 
while K33 is located on the surface of the protein with its side chain projecting away 
from the active site pore.  Two K32 and two K33 residues occur on one end of the pore 
pointing toward the viewer (lower right and upper left), while two symmetry related pairs 
occur on the other end of the pore, pointing away.  The position of the ligands in the 
central pore is shown in stick format.  The pteridine ring of folate (bottom) comes from 
the crystal structure (2), while that of the NMN moiety of NADPH (bottom) derives from 
docking studies (4). Carbon atoms are shown in green, oxygen atoms in red, nitrogen 
atoms in blue, and phosphate in magenta.    
40  
active ternary complex consists of one molecule of NADPH and one molecule of DHF.  
Preferential formation of the active complex occurs due to negative cooperativity in 
binding between NADPH molecules and positive cooperativity between DHF and 
NADPH molecules (3).   
 Because of the symmetry of R67 DHFR, the active site pore is lined with a 
limited number of residues that can participate in catalysis including lysine 32, tyrosine 
46, threonine 51, serine 65, valine 66, glutamine 67, isoleucine 68, and tyrosine 69 (2).  
Lysine 32 (K32) in each monomer is located near the dimer-dimer interface.  The 
sidechain NZ atom of K32 participates in hydrogen bonds with the backbone carbonyl 
groups of serine 34 and alanine 36 in a symmetry related monomer (2).  The orientation 
of the K32 residue in each monomer is such that the side chain projects into the active 
site pore and has the potential to participate in ligand binding and catalysis (Figure 1).  
One proposed role of K32 is an ionic interaction with the 2’phosphate off the AMP ribose 
ring of NADPH ((4) and Narayana, personal communication).  In order to understand the 
role of the K32 residues in ligand binding, this residue was mutated to alanine, arginine, 
glutamine, and methionine.  These mutations were made to either eliminate the 
possibility of an ionic contact with the substrates and/or to vary the potential for 
hydrogen bonding. 
Lysine 33 (K33) is located on the surface of the enzyme with its side chain 
projecting away from the protein (Figure 1) (2).  K33 was also mutated to the nonpolar 
uncharged residue, methionine.  Since K32 and K33 are the only charged residues near 
the active site pore of wt R67 DHFR, mutagenesis of these residues to methionine allows 
investigation of their importance in forming ionic interactions with the substrates 
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NADPH and DHF.  If these residues are involved in an ionic contact(s) with the 
negatively charged substrates, then their replacement should result in weaker binding. 
The importance of K32 and K33 in binding and catalysis is also illustrated by 
their conservation in type II DHFRs (5).  Additionally, both K32 and K33 are proposed 
by DELPHI, a finite Poisson-Boltzmann difference solver, to be involved in generating a 
positive electrostatic potential at the active site which attracts the negatively charged 
substrates (NADPH and DHF) and facilitates binding (4).   
Materials and Methods 
Mutagenesis   
A synthetic R67 DHFR gene, cloned into a pUC8 vector (6), was used for PCR 
mutagenesis reactions.  The oligonucleotide primers for the coding strand used to 
generate mutations in the R67 DHFR gene corresponding to the amino acid positions 32 
and 33 using the Stratagene QuikChange Mutagenesis Kit were as follows:  
5’GGGTGACCGCGTACGTAAAAAATCCGGAGCCGCC3’ (K32A), 
5’GGGTGACCGCGTACGTAGGAAATCCGGAGCCGCC3’ (K32R), 
5’GGGTGACCGCGTACGTCAGAAATCCGGAGCCGCC3’ (K32Q), 
5’GGGTGACCGCGTACGTATGAAATCCGGAGCCGCC3’ (K32M), 
5’GGGTGACCGCGTACGTAAGATGTCCGGAGCCGCC3’ (K33M).  
Mutants were verified by automated fluorescence DNA sequencing at the University of 
Tennessee DNA Sequencing Facility using an ABIPRISM Dye Terminator Cycle 
Sequencing Kit from Perkin Elmer.  Subsequently, R67 DHFR mutants were transformed 
into the SK383 strain of E.coli for protein expression (6, 7). 
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Protein Purification   
Mutant R67 DHFR genes were expressed, and the protein was purified from 
E.coli grown to late stationary phase in TB media (8) at 37°C in the presence of 200 
µg/ml ampicillin and 20 µg/ml trimethoprim (TMP).  K32M mutants were sensitive to 
the presence of TMP and therefore were first grown to visible turbidity before TMP 
addition.  Purification was achieved by a series of steps including G-75 Sephadex, 
DEAE-Fractogel, and Hi-Q column chromatography.  The final step of the purification 
procedure consisted of FPLC column chromatography using a Mono-Q anion exchange 
column.  Purified protein was dialyzed into deionized water and lyophilized for storage at 
–20°C. 
Molecular Sieving Studies   
To determine the apparent molecular weights of the K32A, K32M, and K33M 
mutant proteins, gel filtration using a Superose 12 (HR 10-30) column on a Pharmacia 
FPLC was performed at 4°C.  These studies were conducted at both pH 8 and pH 5 in 
MTA buffer (50 mM Mes, 100 mM Tris, 50 mM Acetic acid).  This buffer maintains a 
constant ionic strength (µ = 0.15) from pH 4-10 (9).  The Kav = (elution volume - void 
volume)/(bed volume – void volume) was calculated for protein standards from the 
Pharmacia Gel Filtration Calibration Kit to generate a standard curve from which the 
molecular weight of R67 DHFR variants was determined.   
Circular Dichroism   
Circular dichroism (CD) spectra were recorded at 22°C in 10 mM potassium 
phosphate buffer, pH 5 and 8 with 10 µM wild type, K32M, or K33M R67 DHFRs using 
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an Aviv Model 202 Series circular dichroism spectrometer.  Data were collected from 
190 nm to 250 nm using a cuvette pathlength of 1.0 mm.  Each spectrum was generated 
using 1nm steps with an integration time of 2 seconds.  A buffer baseline was subtracted 
from each scan and data were subsequently converted to molar ellipticity (θ) using 108 
g/mole as the mean residue molecular weight. 
pH Dependence of Oligomeric-State 
Tryptophan residues were used to monitor the intrinsic fluorescence of the lysine 
mutants as compared to wild-type protein to determine the pH dependent tetramer to 
dimer equilibrium.  The model for the pH dependent equilibrium of R67 DHFR is:  
Koverall 
T + 2nH+⇌ 2DHn                                                                                    (1) 
 
where T is tetramer, D is dimer, DHn is protonated dimer and Koverall equals Ka2n/Kd.  This 
model is based on the findings of Nichols et al., (10), where dissociation of tetramer into 
dimers is linked to the protonation of symmetry related H62 residues located at the 
dimer-dimer interfaces.    
Fluorescence measurements were made using a Perkin-Elmer LS-5B spectrometer 
interfaced to an IBM PS/2 computer.  Tryptophan residues were excited at 295 nm and 
emission was monitored from 300 to 450 nm using 2 µM of wt, K32M, or K33M R67 
DHFRs in MTA polybuffer.  Each sample was titrated with small aliquots of 1N HCl and 
the pH was measured over the range of pH 8-4.  The intensity averaged emission 
wavelength, <λ>, for each emission spectrum was calculated using: 
<λ> = Σ(Iiλi)/Σ(Ii)                                                       (2) 
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where I is intensity, and λ is the wavelength (11).  The fluorescence data were fit to 
equation 5 in Nichols et al., (10) using a non-linear regression subroutine of the Statistical 
Analysis Systems package (SAS, Cary, NC).  Finally, fitting to the following equation 
normalized the data:  
 
Fapp = (Yobs-YpH8)/(YpH4-YpH8)                                              (3) 
 
 
where Fapp is a fractional value between 0 and 1, and Yobs, YpH8, and YpH4 are the optical 
values associated with the observed pH and with the pH limits of 8 and 4, respectively.   
This same analysis was performed with 2 µM wild-type R67 DHFR in MTA 
buffer pH 8 (µ=0.15).  NaCl was added to adjust the ionic strength to 0.25, 0.5, and 0.75 
to determine salt effects on the pH dependent oligomerization of wild-type R67 DHFR.   
Fluorescence Quenching 
 
Binding of NADPH to 2.5 µM R67 DHFR was monitored in TE buffer (10 mM 
Tris, 1 mM EDTA, pH 7) using tryptophan fluorescence as per Zhuang et al. (12).  Data 
were fit to:  
 
Fl = Fo – 0.5 Fo [Ptot + Kd + Ltot – [(Ptot + Kd + Ltot)2 – 4 Ptot Ltot)1/2]               (4) 
 
 
where Fl is the observed fluorescence, Ltot is the total ligand concentration, and Ptot, Kd 
and Fo are variables describing the number of enzyme binding sites, dissociation constant, 
and fluorescence yield per unit concentration of enzyme, respectively (13).   
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Isothermal Titration Calorimetry 
ITC experiments with NADPH or folate as titrant were performed in TE buffer 
pH 7 at 28°C in the presence of NaCl to adjust the ionic strength.  Protein concentrations 
used for these experiments varied between 100-150 µM.  Binding affinities and 
enthalpies associated with binding were measured as previously described (3).  Binding 
of NADPH or folate to wt R67 DHFR was measured using a Microcal VP isothermal 
titration calorimeter.  The data were collected by an IBM personal computer running 
DSCITC Software and were fit using Origin version 5.0 software.  Baseline correction of 
the data was performed by injecting ligand into buffer.  ITC was also done with the 
K33M mutant to determine the ∆H and the associated Kd values for NADPH binding in 
MTA buffer pH 8.  Finally, binding of folate to a 1:1 mix of R67 DHFR:NADPH was 
performed at 13oC (in TE buffer, pH 7) as previously reported (3).  Instrument design and 
operation are explained by Wiseman et al., (14). 
Kinetic Analysis  
Steady-state kinetic data for the K33M mutant were obtained using the computer 
program UVS (Softways) on a Perkin-Elmer λ3a spectrophotometer interfaced with an 
IBM PS/2 (15).  Kinetic assays were performed at 30°C in MTA polybuffer pH 7.  The 
kinetic parameters Km (DHF), Km (NADPH) and kcat were determined under subsaturating 
conditions by maintaining a constant concentration of one ligand while varying the 
concentration of the other ligand.  This was done at five or more different subsaturating 
ligand concentrations.  Data were globally fit using a non-linear regression analysis 
performed by SAS (16).  The extinction coefficients used were 28,000 M-1cm-1 at 282 nm 
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for DHF (17), 6220 M-1cm-1 at 340 nm for NADPH (18), and 12,300 M-1cm-1 at 340 nm 
for the reaction (19). 
Kinetic analysis was also performed to determine ionic strength effects on the 
steady-state kinetics parameters for wt and K33M R67 DHFRs.  These assays were 
conducted at 30°C in TE buffer, pH 7 (µ = 0.02) with NaCl added to adjust the ionic 
strength to 0.15, 0.22, 0.32, and 0.42.  Salt effects were also examined using NaF (µ from 
0.1 to 0.62) and NaSCN (µ from 0.1 to 0.18).  Salt effects were also tested with wt R67 
DHFR using the alternate cofactor, NADH.  Kinetic assays were monitored at 360 nm to 
allow use of higher ligand concentrations to bracket the Km values.  Extinction 
coefficients at this wavelength were calculated as 2630 M-1cm-1for DHF, 4020 M-1cm-1 
for NADH, and 5020 M-1cm-1 for the reaction.   
Results 
 
Effects of Mutations 
 
Molecular Sieving Studies   
The K32A, K32M, K32Q and K32R mutants provided minimal resistance to 
TMP, while the K33M mutant readily allowed cell growth in media containing TMP.  
TMP sensitivity has previously been observed in mutants that destabilize the active 
homotetramer (10, 20).  Therefore, the oligomeric state of each purified mutant protein 
was analyzed by the elution pattern on a molecular sieving column at pH 8 and 5.   At pH 
8, wt R67 DHFR elutes as a tetramer, however at pH 5, wt R67 DHFR elutes as a dimer 
(10).  The K32M and K32A mutants have approximate molecular weights at both pHs 8 
and 5 that correspond to the dimeric form of R67 DHFR (Table 1).  Since K32 occurs 
near the dimer-dimer interface, these four symmetry related mutations have a cumulative  
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Table 1.  Molecular sieving experiments conducted with wt, K32M, and 
K33M R67 DHFRs in MTH buffer pH 8 and pH 5. 
 
 
 
 
 
 
DHFR Species Molecular Weight 
(daltons) 
 
pH 8 
Molecular Weight
(daltons) 
 
pH 5 
WT R67 DHFR 
 
39,000 ± 810 25,000 ± 120 
K32A R67 DHFRa 
 
29,000 ± 150  25,700 ± 980 
K32M R67 DHFR 
 
25,000 ± 120 25,000 ± 120 
K33M R67 DHFR 37,000 ± 650 24,000 ± 800 
a Hamilton, thesis 
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effect and destabilize the tetramer.  In contrast, the K33M mutant has similar estimated 
molecular weights at pH 8 and 5 to wt R67 DHFR, suggesting it maintains the 
homotetrameric form over the pH ranges of our experiments.     
Circular Dichroism   
To examine the effect of the mutations on the secondary structure of R67 DHFR, 
CD was performed at both pHs 8 and 5 (Figure 2).  The mutants show smaller signals 
compared to wt at both pH 8 and 5.  In the case of the K33M mutant, this small 
difference may be due to a change in the local environment that occurs as a result of the 
mutation (21).  The CD spectra, in addition to the molecular sieving and pH titration data, 
illustrate that the K33M mutant is comparable to wt in conformation.  On the other hand, 
the K32M mutant shows a significant difference in the CD spectra consistent with the 
molecular sieving and pH titration data that this mutant is dimeric. 
pH Dependence of Oligomeric-State   
To provide a more quantitative evaluation of the effect of the mutations on the 
tetramer to dimer equilibrium, tryptophan fluorescence was monitored as a function of 
pH.  Specifically, the tryptophan 38 (W38) residues that occur at the dimer-dimer 
interface can be utilized to monitor changes in the local environment since in the 
tetrameric form of R67 DHFR these residues are buried in a hydrophobic environment, 
whereas in the dimeric form of R67 DHFR these residues are solvent exposed.  This 
equilibrium is linked to the protonation of histidine residues.  Titration of the four 
symmetry related histidine 62 residues located at the dimer-dimer interfaces results in 
protonation and destabilization of the tetramer into dimers (10).  
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Figure 2.  Circular dichroism spectra for wt, K33M, and K32M DHFRs.  Panel A 
illustrates the spectra for wt (       ), K33M (       ), and K32M (        ), at pH 8.  Panel B 
illustrates the spectra for these proteins at pH 5. 
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pH titrations for wt, K32M and K33M R67 DHFRs are shown in Figure 3.  The 
wt and K33M enzymes show a titration consistent with a tetramer (pH 8) to two dimers 
(pH 5) transition.  In contrast, the K32M (and K32A not shown) mutant does not, 
consistent with it remaining dimeric throughout this pH range.  The pH titration data for 
wt and K33M R67 DHFRs were fit (10) and best-fit values are given in Table 2.  The 
Koverall value for the K33M mutant is similar to that for wt R67 DHFR where the best fit 
occurs with 2n=3, and 2n represents the number of protons added to the dimer-dimer 
interfaces resulting in dissociation of the tetramer.  Since the K33 residues are located on 
the surface of the protein at the edge of the active site pore, the mutation was expected to 
have a minimal effect on the oligomeric state of the enzyme.  Accordingly, the Koverall 
values are similar to wt R67 DHFR.    
 Tryptophan fluorescence as a function of pH was also monitored with wt R67 
DHFR in the presence of 0.25M, 0.5M, and 0.75M NaCl to determine the effects of salt 
on the oligomeric state of the protein (Figure 4).  Addition of salt slightly destabilizes the 
tetramer.  At pH 7, where most of the kinetic and binding experiments were performed, 
the majority of the protein is tetrameric so any observed salt effects are not due to a shift 
in the tetramer to dimer equilibrium.       
Binding and Steady State Kinetic Analysis 
 
Steady state kinetics were performed with wt and mutant DHFRs (Table 3).  
Kinetic analysis of the K32M mutant could not be readily performed due to its low 
activity.  The low activity correlates with loss of the active site pore upon dimer 
formation.  Previous kinetic analysis of dimeric R67 DHFRs indicates low activity (10, 
20); however the activity of the K32 mutants is even lower, suggesting an additional  
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Figure 3.  pH titrations of wt (?), K32M (?), and K33M (?) R67 DHFRs to monitor 
the pH dependence of the oligomeric state. At pH 8, wt R67 DHFR is a tetramer while at 
pH 5 it is a dimer.  Best fits are represented by a solid line for wt R67 DHFR and a 
dashed line for K33M R67 DHFR (10).  Koverall values are given in Table 2 for 2n=3.  
Since the K32M data do not show a transition and the center of mass value corresponds 
more closely to the wt dimer value, we conclude that the K32M mutant remains dimeric 
throughout this pH range. 
52  
  
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Best-fit values for the T + 2nH+⇌ 2DHn equilibrium  
 monitored by fluorescence.
DHFR Species/Condition Koverall (= Ka2n/Kd) 
for 2n=3 in units of M2 
WT R67 DHFR 2.5 x 10–13 ± 9.1 x 10-15 
 
K33M R67 DHFR  1.1 x 10-13 ± 6.1 x 10-15 
 
wt R67 DHFR (0.25M NaCl) 5.9 x 10-14 ± 2.9 x 10-15 
 
wt R67 DHFR (0.5M NaCl) 3.8 x 10-14 ± 2.0 x 10-15 
 
wt R67 DHFR (0.75M NaCl) 3.3 x 10-14 ± 1.5 x 10-15 
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Figure 4.  Effects of increasing salt on the pH dependent oligomeric state of wt R67 
DHFR were monitored at NaCl concentrations of 0M (?), 0.25M (?), 0.5M (?), and 
0.75M(?).  Addition of salt shifts the titration, however the effect is not great.  Best-fit 
values are given in Table 2. 
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Table 3.  A comparison of steady-state kinetic values for K33M 
and wt R67 DHFRs in MTA buffer, pH 7.   
               
 
 
 
 
 
 
DHFR Species 
 
Km (NADPH)   
(µM) 
Km (DHF) 
(µM) 
kcat  
(s-1) 
WT R67 DHFRa 
 
3.0 ± 0.06 5.8 ± 0.02 1.3 ± 0.07 
K33M R67 DHFR 12 ± 1.8 14 ± 0.09 1.7 ± 0.13 
a from Reece et al., (6). 
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affect of the mutation on binding and catalysis.  In contrast, steady state kinetics could be 
performed for the K33M mutant.  This mutant displays a 2-fold increase in the Km for 
DHF and a 4-fold increase in the Km for NADPH.  There was also a slight increase in kcat.  
Additionally, binding of NADPH to this mutant was monitored by ITC (Table 4).  
Negative cooperativity is observed during NADPH binding, with one tight site and one 
weak site.  The K33M mutation weakens binding to these sites by 8- and 7-fold, 
respectively.  Together, these results suggest that K33, located on the surface of R67 
DHFR, plays a minor role in binding both cofactor and substrate in the active site pore.    
Ionic Strength Effects 
Since the role of K32 could not be evaluated directly through a site-directed 
mutagenesis approach, its ability to participate in ionic interactions was evaluated 
through salt effects on wt and K33M R67 DHFRs.   Ligand binding was first evaluated, 
followed by steady state kinetic analysis.  
Fluorescence Quenching with NADPH   
The binding of NADPH as affected by ionic strength was determined by 
monitoring fluorescence quenching.  The sensitivity of this technique only allows 
monitoring of binding at the first tight site, Kd1.  As the ionic strength is increased 
(µ=0.04-0.27), the Kd1 (NADPH) also increases (0.35-20µM) (Table 5).  The slope of a log-
log plot of Kd1 (NADPH) vs. ionic strength is 2.0 ± 0.3 (Figure 5).  The slopes of these types 
of plots have previously been taken to describe Z, the number of ionic interactions 
involved in binding (22-24).  Due to the high Kd1 associated with binding of DHF (125 
µM), Kd (DHF) values could not be measured using this approach.   
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Table 4.  Binding of NADPH to wt and K33M R67 DHFRs in MTA buffer (pH 8) as 
measured by ITC.     
a Data from Bradrick et al., (3). 
DHFR 
Species 
Kd1 (NADPH) 
(µM) 
∆H1 (cal/mol) Kd2 (NADPH) 
 (µM) 
∆H2 (cal/mol) 
wt R67 
DHFRa 
5.0 ± 0.3 -8600 ± 200 48 ± 2.0 -5800 ± 250 
 
K33M DHFR 19 ± 0.3 -6500 ± 22 630 ± 29 -530 ± 55 
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Table 5.  Determination of Kd1 (NADPH) in wt 
R67 DHFR using a fluorescence quenching 
approach (TE buffer, pH 7). 
Ionic 
Strength  
(µ) 
Kd (NADPH) 
(µM) 
 
0.04 0.35 ± .01 
 
0.05 0.65 ± 0.09 
 
0.07 0.86 ± 0.01 
 
0.09 1.5 ± 0.2 
 
0.11 3.3 ± 0.5 
 
0.15 7.5 ± 0.7  
 
0.18 7.9 ± 0.8 
 
0.21 14 ± 4 
 
0.22 15 ± 0.7 
 
0.27 20 ± 0.1 
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Figure 5.  Log-log plot of Kd (NADPH) vs. ionic strength.  The Kd as determined by 
quenching of R67 DHFR fluorescence upon NADPH addition.  Kd values are given in 
Table 5.  As the ionic strength is increased, the Kd (NADPH) increases.  
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Isothermal Titration Calorimetry with NADPH  
  
To gain additional information on the effects of ionic strength on NADPH 
binding, ITC was also used.  The shape of the titration curves varied, with a sigmoidal 
plot observed at µ = 0.02 and a hyperbolic plot at µ =0.32.  At high ionic strength, the 
second molecule of NADPH either does not bind (i.e., cooperativity is altered) or binding 
becomes sufficiently weak that we are unable to saturate this site.  This suggested use of 
a single site model for fitting, and at intermediate values of µ, fitting to this model gave 
reasonable fits.  (Also fitting to 2 sites consistently yielded one Kd equivalent to the 
single site model).  Values obtained from these titrations are shown in Table 6 and  
Figure 6.  Kd1 (NADPH) increases from 0.4 to 47 µM as µ increases from 0.02 to 0.3.  The 
slope of the log-log plots for Kd1 (NADPH) vs. ionic strength is 1.8 ± 0.08.  In addition, the 
total heat evolved (q Total) decreases with increasing ionic strength, consistent with loss of 
ionic interactions.  These results, in conjunction with the fluorescence quenching data 
above, indicate two ionic interactions are involved in binding the first NADPH molecule.  
Isothermal Titration Calorimetry with Folate   
ITC was also used to monitor salt effects on folate binding.  The poor substrate, 
folate, was used in these experiments instead of DHF, since salt destabilizes DHF over 
the time period required to run an ITC experiment.  Folate is similar in structure to DHF 
except that it possesses a double bond between C7 and N8.  In these experiments, we are 
unable to consistently fit the titrations for folate binding to two sites, suggesting the 
occurrence of an additional process during binding.  One possibility might involve some 
effect associated with binding of folate dimers from solution.  Dimerization of folate has 
previously been reported (25).  Even with this potential complication, we can  
60  
 
 
 
 
 
 
Table 6.  Isothermal titration calorimetry data describing 
binding of NADPH to wt R67 DHFR in TE buffer (pH 7) 
with NaCl added to adjust the ionic strength.  
Ionic Strength 
(µ) 
Kd1 (NADPH) 
(µM) 
∆H1 (cals/mol) 
 
0.02 0.4 ± 0.04 -8949 ± 30 
 
0.02 0.35 ± 0.03 -8814 ± 30 
 
0.07 0.63 ± 0.02 -7781 ± 60 
 
0.07 0.61 ± 0.2  -7986 ± 50 
 
0.12 16 ± 0.07 -7806 ± 40 
 
0.12 16.2 ± 0.06 -6870 ±38 
 
0.15 14 ± 0.07 -7692 ± 50 
 
0.15 14.6 ± 0.03 -7513 ±120 
 
0.22 34.9 ± 0.06 -4992 ±130 
 
0.22 37.7 ± 0.02 -6341 ± 50 
 
0.27 47.5 ± 0.01 -4617 ± 80 
 
0.27 46.6 ± 0.01 -4472 ± 70 
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Figure 6.  Effects of increasing ionic strength on binding of NADPH to wt R67 DHFR as 
monitored by ITC.  Kd values were measured for the tight site, Kd1 (NADPH) as shown in 
panel A.  As the ionic strength increases, the Kd (NADPH) increases. The corresponding 
qTotal values (total heat) decrease with increasing ionic strength, as shown in panel B.  
Experiments were performed at ionic strengths of 0.02 (?), 0.07 (?), 0.12 (?), 0.15 
(?), 0.22 (?), and 0.32 (?).  Kd values are listed in Table 6. 
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qualitatively note the effect of increasing ionic strength on folate binding by plots of total 
enthalpy (q Total) vs. folate concentration.  This plot reveals that the binding process is less 
exothermic (i.e., involves lower enthalpy values) as the concentration of salt increases 
(Figure 7).  Increasing µ has a clear effect; however, we are unable to extract the number 
of interactions disrupted.  
Binding of folate to a 1:1 mixture of R67 DHFR:NADPH was also performed in 
varying salt concentrations.  One folate molecule binds to form the ternary complex, and 
the Kd values in Table 7 show no evidence of a titration.  However a titration is observed 
when the ∆H values are evaluated.  At low ionic strength, ∆H remains constant at 
approximately -13,000 cal/mol.  Only one intermediate point was monitored before a 
second plateau in ∆H is observed (at approximately -5800 cal/mol).  This titration 
indicates folate binding is salt dependent in the ternary complex, and since the titration is 
complete by a µ of 0.22, the ionic interaction must be weaker than those observed in 
either the 2 NADPH or the 2 folate complexes.   
Steady-State Kinetic Analysis in Presence of Salt   
Salt effects on steady state kinetics were also performed with wt and K33M R67 
DHFRs to investigate further the importance of ionic interactions in ligand binding and 
catalysis.  As the buffer is changed from MTA to TE, minor differences in Km are 
noticed.  More interestingly, as the ionic strength is increased, the binding of both 
cofactor and substrate is weakened.  In addition, the kcat values increase. Concentrations 
of up to 0.4M NaCl were used to examine salt effects (Table 8).      
            To quantify the number of ionic interactions involved in ligand binding and 
catalysis, log-log plots of the steady state kinetic data vs. ionic strength were generated.   
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Figure 7.  Effects of ionic strength on the total heat of folate binding as measured by 
ITC.  The protein concentration was 100 µM for all experiments.  The total heat observed 
upon folate addition is plotted at various ionic strengths (µ=0.15 (?), µ=0.22 (?), 
µ=0.27 (?), and µ=0.32 (?)).    
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Table 7.  Isothermal titration calorimetry data for folate binding to a 1:1 mixture 
of R67 DHFR:NADPH at 13°C in TE (pH 7) in the presence of various salt 
concentrations to adjust the ionic strength.  These data were fit to a single site 
model using the Origin software. 
Ionic Strength Kd (µM) n ∆H (cal/mol) # of 
Experiments 
0.02 11.0 ± 0.4 0.95 -13100 ± 180 
 
2 
0.07 20.0 ± 1.0 1.0 -13300 ± 390 
 
2 
0.15 15.2 ± 0.4 1.0 -8300 ± 67 
 
2 
0.22 9.5 ± 0.7 0.98 -5700 ± 130 
 
2 
0.27 13.3 ± 0.8 0.99 -5800 ± 150 
 
2 
0.32 12.8 ± 0.8 1.1 -5700 ± 100 2 
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Table 8.  Steady-state kinetic values for wt and K33M R67 DHFRs 
in TE (pH 7) in the presence of NaCl to adjust the ionic strength (µ). 
R67 DHFR Species 
NaCl concentration 
(ionic strength) 
 
Km (NADPH) 
(µM) 
Km DHF 
 (µM) 
kcat  
(s-1) 
wt R67 DHFR 
0.13M  
(µ=0.15) 
 
 
8.7 ± 0.4 
 
 
13 ± 0.7 
 
1.5 ± 0.04 
 0.2M  
(µ=0.22) 
 
13 ± 0.8  29 ± 1.8 2.0 ± 0.1 
0.3M   
(µ=0.32) 
 
26 ± 1.3 54 ± 2.5 2.8 ± 0.1 
 
0.4M  
(µ=0.42) 
41 ± 2.3 81 ± 4.3 3.7 ± 0.2 
K33M R67 DHFR 
0.13M 
(µ=0.15) 
 
33 ± 1.3 
 
 
25 ± 1.3 
 
2.3 ± 0.1 
 
0.2M 
 
50 ± 3.0 
  
32 ± 1.9 
 
2.2 ± 0.01 
(µ=0.22) 
 
   
0.25M 
(µ=0.27) 
 
68 ± 3.5  53 ± 2.2 3.3 ± 0.1 
0.3M 
(µ=0.32) 
 
91 ± 5.5 88 ± 5.3 3.9 ± 0.2 
 
0.35M 
(µ=0.37) 
170 ± 6.4 140 ± 4.5 5.5 ± 0.1 
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These plots are shown in Figure 8 and their corresponding slopes are given in Table 9.  
Surprisingly, there is a linear relationship between ionic strength and kcat for the R67 
DHFR reaction.  The slope of the log-log plot for the wt enzyme is 0.9 ± 0.08.  
Additionally, slopes of 1.8 ± 0.2 and 1.5 ± 0.1 for the log-log plots of ionic strength vs. 
Km (DHF) and Km (NADPH) are observed for wt R67 DHFR.  Finally, since ionic strength 
effects on kcat result in rate enhancements (slope effects of ~1), while salt effects on Km 
are consistent with weaker binding (slope effects of ~2), the overall effect on kcat/Km is a 
net decrease in catalytic efficiency (slope effects of approximately -1).  These results, in 
conjunction with the above binding studies, suggest a model where 2 salt sensitive 
interactions are involved in initial ligand binding, however one of these interactions is 
lost as the ground state proceeds towards the transition state.   
 A comparison of the salt effects on wt and K33M R67 DHFRs shows that the 
slopes of the various plots are quite similar (Table 9).  We conclude K33 is not the 
residue responding to the presence of salt. 
Effect of Different Salts on Binding   
To evaluate if these salt effects on wt R67 DHFR are due to a non-specific and/or 
or a salt specific effect resulting in disruption of an ionic interaction, kinetic 
characterization was also performed in the presence of NaF as well as NaSCN (26-28).  
The steady-state data are given in Tables 10 and 11 and are represented graphically in 
Figure 9.  The abbreviated Hofmeister series (SCN-, I-, Br-, Cl-, F-) indicates F- has a high 
charge density and a high energy of hydration, making it least able to compete with a 
charged ligand for binding.  Cl-, in the middle of the Hofmeister series, has a neutral 
effect, while SCN-, with a lower charge density and lower energy of hydration, is more  
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Figure 8.  Log-log plots of steady-state kinetic values vs. ionic strength for wt and K33M 
R67 DHFRs.  Kinetics were performed with wt (?, ∆) and K33M (?, Ο) R67 DHFRs in 
the presence of increasing NaCl concentrations.  Panels A and B show the effects on 
kcat/Km with insets showing the effects on the respective Kms.  Panel C shows the effect 
of increasing salt on kcat. The values are given in Table 8 and the slopes are presented in 
Table 9.   
68  
 
 
 
 
 
 
 
 
 
 
 
Table 9.  Slopes of the log-log plots for kcat/Km (NADPH), kcat/Km (DHF), kcat, and 
Kms as a function of ionic strength for wt and K33M R67 DHFRs in the 
presence of NaCl or NaF.   
R67 DHFR 
Species 
(Salt) 
 
 
slope of 
kcat/Km 
(NADPH) 
plot 
slope of 
kcat/Km 
(DHF) 
 plot 
slope of 
kcat  
plot 
slope of 
Km 
(NADPH) 
plot 
slope of 
Km (DHF) 
plot 
wt R67 DHFR 
(NaCl) 
 
-0.6 ± 0.09 -0.9 ± 0.03 0.9 ± 0.08  1.5 ± 0.1 1.8 ± 0.2 
wt R67 DHFR 
(NaF) 
      
-0.9 ± 0.2  
 
-0.8 ± 0.08 0.9 ± 0.2 1.7 ± 0.4 1.6 ± 0.2 
wt R67 DHFR 
(NaSCN) 
 
-1.6 ± 0.2 -1.5 ± 0.2 0.7 ± 0.3 2.2 ± 0.2 2.2 ± 0.2 
K33M DHFR 
(NaCl) 
-0.7 ± 0.03 -0.9 ± 0.09 1.0 ± 0.3  1.7 ± 0.2 1.9 ± 0.4 
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Table 10.  Steady-state kinetic values for wt R67 DHFR in the presence of 
increasing concentrations of NaF in TE, pH 7.   
wt R67 DHFR  
NaF concentration 
(ionic strength) 
 
Km (NADPH) 
(µM) 
Km (DHF) 
 (µM) 
kcat  
(s-1) 
0.08M  
(µ=0.12) 
 
1.7 ± 0.02 4.6 ± 0.3 1.0 ± 0.01 
 
0.13M  
(µ=0.15) 
 
6.4 ± 0.3 
 
11 ± 0.5 1.8 ± 0.05 
0.3M   
(µ=0.32) 
 
15 ± 0.9 30 ± 1.6 2.5 ± 0.1 
 
0.6M  
(µ=0.62) 
42 ± 2.8 81 ± 6.2 4.7 ± 0.3 
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Table 11.  Salt effects on the kinetic parameters for wt R67 DHFR in 
the presence of TE, pH 7 with various concentrations of NaSCN  
added to adjust the ionic strength. 
NaSCN 
concentration 
(ionic 
strength) 
 
Km (NADPH) 
 (µM) 
Km (DHF)  
(µM) 
kcat  
(s-1) 
0.08 
(µ=0.06) 
 
4.9 ± 0.3 12.7 ± 0.2 1.3 ± 0.01 
0.1 
(µ=0.08) 
 
7.8 ± 0.4 21.7 ± 0.9 1.2 ± 0.02 
0.12 
(µ=0.1) 
 
12.3 ± 0.7 38.6 ± 1.9 1.8 ± 0.02 
0.15 
(µ=0.13) 
 
24.5 ± 1.2 57.6 ± 2.6 2.4 ± 0.01 
0.18 
(µ=0.16) 
28.3 ± 1.3 69.8 ± 2.8 1.9 ± 0.02 
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Figure 9.  Steady-state kinetics performed with wt R67 DHFR in NaF (?) compared to 
the kinetic values obtained in the presence of NaCl (?) and NaSCN (?). The plots of log 
kcat/Km vs. log ionic strength reveal that the effect of salt on the slope is the same for 
NaCl and NaF but NaSCN affects the slope differently (panels A and B). The kinetic 
values are given in Tables 8, 10, and 11 and the slopes are in Table 9. 
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able to compete for binding (26-29).   Thus, the use of different salts allows specific 
anion effects to be discerned from ionic strength effects.  While the absolute values for 
kcat and Km are somewhat different, comparison of the slopes for the NaCl and NaF plots 
yields values within error of each other, suggesting there is not a significant difference 
depending on anion type (Table 9).  However extending the comparison to NaSCN shows 
a different slope for kcat/Km values, suggesting the presence of specific anion effects.  
NADPH versus NADH Binding  
 To probe whether the 2’ phosphate off the adenine ribose of NADPH is involved 
in one of the ionic interactions with wt R67 DHFR, the alternate cofactor NADH was 
used in steady state kinetic analysis.  DHF inhibition is noted, particularly at low ionic 
strengths, perhaps arising from weaker binding of NADH and less positive cooperativity 
between NADH and DHF, which allows more ready formation of the inhibitory 2DHF 
complex.  Since fitting data sets displaying inhibition using SAS requires some 
knowledge of the various Kds involved (16), we are not certain that the output is as 
accurate as our kinetic data generated in the absence of inhibition.  A qualitative 
observation is that the rate clearly increases with increasing salt concentration, as do the 
Km values (Figure 10 and Tables 12 and 13).  That the rate increases using either NADPH 
or NADH as cofactor while ionic strength concurrently increases suggests the ionic 
interaction broken going from the ground state to transition state involves the PPi bridge, 
since this is the common negatively charged moiety.  
There is no obvious DHF inhibition observed when NADH is used at µ=0.32 and 
the steady state kinetic data can be fit easier.  Table 14 shows the Km for NADH is 12  
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Figure 10.  Salt effects on NADH binding to wt R67 DHFR.  In the presence of TE, pH 7 
with various concentrations of NaCl to adjust the ionic strength, NADH binding is salt 
sensitive in the ground state (insets in panels A and B) compared to the transition state 
(panels A and B).  Kinetic values are illustrated in Tables 12 and 14 and slopes are given 
in Table 13. 
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Table 12. Steady-state kinetics describing NADH binding to wt R67 
DHFR in TE (pH 7) buffer in the presence of various amounts of 
NaCl to adjust the ionic strength. 
Ionic Strength 
(µ) 
Km (NADH) 
(µM) 
Km (DHF) 
(mM) 
kcat (s-1) 
 
0.08 
(µ=0.1) 
 
57 ± 1.6 68 ± 1.7 0.22 ± 0.01 
 
0.13 
(µ=0.15) 
 
80 ± 3.4 162 ± 20 0.5 ± 0.03 
 
0.18 
(µ=0.2) 
 
94 ± 3.6 220 ± 19 0.48 ± 0.02 
 
0.30 
(µ=0.32) 
320 ± 17 250 ± 16 0.7 ± 0.04 
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Table 13.  Slopes of log-log plots of kinetic parameters vs. ionic strength for wt R67 
DHFR in the presence of NADPH and NADH.
wt R67 DHFR 
 
 
slope of 
kcat/Km 
(NADPH) 
plot 
slope of 
kcat/Km 
(DHF) 
 plot 
slope of 
kcat  
plot 
slope of 
Km 
(NADPH) 
plot 
slope of 
Km (DHF) 
plot 
NADPH 0.6 ± 0.09 0.9 ± 0.03 0.9 ± 0.08 1.5 ± 0.1 1.8 ± 0.2 
 
NADH 0.3 ± 0.4 0.2 ± 0.03 1.0 ± 0.3 1.3 ± 0.3 1.4 ± 0.3 
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Table 14.  Steady-state kinetic values for wt R67 DHFR with 
NADH in the presence of 0.3M NaCl TE, pH 7.   
wt R67 DHFR  
cofactor 
(ionic strength) 
 
Km (cofactor) 
(µM) 
Km (DHF) 
 (µM) 
kcat  
(s-1) 
NADH  
(µ=0.32) 
 
320 ± 17 250 ± 16 0.7 ± 0.04 
NADPH 
(µ=0.32) 
26 ± 1.3 54 ± 2.5 2.8 ± 0.1 
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fold higher than that for NADPH and the kcat value is decreased 4 fold.  This combines to 
increase kcat/Km (cofactor) 50 fold.  The Km for DHF is also affected, being 4.6 fold higher.  
Measurements of Km values for NADH were not made beyond an ionic strength of 0.32 
due to limitations in the range of the spectrophotometer.  An increase in Km (NADH) 
compared to Km (NADPH) for R67 DHFR has previously been observed by Smith and 
Burchall (30).  Similar fold effects have also been seen in E. coli DHFR where R44L and 
H45Q mutations were constructed to evaluate the role of these residues in binding the 
2’phosphate and PPi moieties of NADPH (31).  The R44L and H45Q mutations altered 
the Kd for NADPH (monitored by fluorescence quenching) by 11 and 6 fold respectively, 
while binding of dihydrofolate was unaltered.  Effects on the hydride transfer step were 
21 and 3 fold decreases respectively.  Together, these data illustrate the importance of the 
2’phosphate moiety in different DHFR scaffolds by the large effects on binding in the 
absence of this group.   
Discussion 
The role of ionic interactions in binding and catalysis in R67 DHFR has been 
investigated.  The following observations indicate that ionic interactions play a role in 
these processes.  1) Fluorescence quenching and ITC data reveal that Kd1 (NADPH) increases 
with increasing ionic strength.  2) ITC experiments show qTotal associated with NADPH 
binding becomes less negative as ionic strength increases.  3) ITC data demonstrate 
binding of 2 folate molecules is a salt sensitive process.  4) Calorimetry experiments 
show a titration in ∆H for folate binding to R67 DHFR•NADPH that is complete by a µ 
of 0.22.  5) Salt effects are observed by monitoring the steady state kinetic behavior of 
the wt enzyme in buffers of increasing ionic strength.  Higher Kms for NADPH and DHF 
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are observed as salt concentration increases as well as an enhancement of kcat.  6) Similar 
salt induced slope effects are observed for the wt and K33M enzymes.  The only charged 
residues near the active site in this mutant are the symmetry related K32 residues.  7) Our 
mutagenesis studies implicate only a minor role for K33 in binding illustrated by the 2-4 
fold weaker Km values for the K33M mutant.  The fold changes associated with the 
K33M mutant are smaller than the observed salt effects.  8) There is a 50 fold effect on 
kcat/Km (cofactor) in the presence of NADH at µ= 0.32, suggesting the 2’ phosphate is 
involved in an ionic interaction with R67 DHFR.  9) pH titration studies reveal that 
increasing the concentration of NaCl up to 0.75M does not affect the stability of the 
enzyme.   
Quantitation of the Number of Ionic Interactions Involved in Ligand Binding  
Quantitating the number of ionic interactions involved in ligand binding was first 
described by Record et al., in 1976 using various proteins binding to DNA (22).  
Recently, Park and Raines (23) have described the requirements for quantitating the 
number of ionic interactions involved in ligand binding and catalysis using salt-rate 
profiles.  One of the conditions is that an increase in the concentration of salt does not 
cause a decrease in the stability of the enzyme.  pH titration studies with wt R67 DHFR 
reveal that increasing the NaCl concentration up to 0.75M does not significantly affect 
the conformation of this enzyme.  In addition, to be able to use salt effects to 
quantitatively monitor ionic interactions, the kcat should reflect the chemical step, not 
product release (23).  Hydride transfer is the rate-determining step in the R67 DHFR 
reaction as monitored by NADPD isotope effects (32).  Another preference is for the 
assays to be monitored at the pH optimum to minimize any pH effects.  This criterion 
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was not met with respect to R67 DHFR, as activity increases as the concentration of 
protonated DHF increases (N5 pKa of 2.59) (23, 33).  This titration is masked however as 
the active site pore in the wt homotetramer is lost upon dissociation into dimers (Figure 
2A).  While this criterion was not met, the assay pH was carefully maintained at pH 7.0 
and any systematic alterations in pH should be minimal and would not be expected to 
propagate into large (unitary) slope effects.   Finally, variance of the anion character 
should minimally affect the slope of the resulting plots.  While the slopes describing 
steady state kinetic parameters of R67 DHFR are similar in NaCl and NaF, higher slopes 
for kcat/Km are observed in NaSCN.  A different effect by SCN- suggests the additional 
presence of specific anion effects.  A recent study of lysozyme crystal structures obtained 
in different salts (NaI, NaNO3, KSCN and p-toluene sulfonate) shows the presence of 
common anion sites as well as specific sites (34).   Binding strategies include contacts 
with Arg and Lys sidechains as well as H-bonds with other residues (either side- or main-
chain).  Thus while specific anion sites apparently occur in R67 DHFR, the likelihood of 
common anion sites remains reasonable.  Another instance of general ionic strength 
effects augmented by specific anion effects has also been noted by Lee et al. in measuring 
different salt effects on the pKas of histidines in Staphylococcal nuclease (35).  
How Many Ionic Interactions are Involved in Ligand Binding   
Log-log plots of Kd (NADPH) vs. ionic strength, from both fluorescence quenching 
and ITC studies, display slopes of ~2.  These combined results suggest two ionic 
interactions are likely to be involved in binding each NADPH molecule in the presence of 
NaCl.  This is also observed by a 50-fold decrease in catalytic efficiency using NADH as 
a cofactor (involvement of 2’phosphate) as well as a salt effect on kcat using NADH. 
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 We have been unable to obtain Kd values for DHF/folate by either fluorescence 
quenching or ITC under various salt conditions.  However folate binding under binary 
complex conditions is salt sensitive as shown in Figure 7.  In contrast, folate addition to 
the R67 DHFR•NADPH complex shows no change in Kd values coupled to a titration in 
enthalpy that is complete by a µ of 0.22.  These results suggest different salt sensitivities 
for the R67 DHFR•2 folate and R67 DHFR•NADPH•folate complexes. 
 The observation that the Kd for folate binding to the ternary complex does not 
vary while a titration in ∆H is observed invokes enthalpy-entropy compensation (36-39).  
In this process, the unvarying Kd describes ∆G as ∆G = -RT ln Ka where Ka is the 
association constant and equals 1/Kd.   For a titration in ∆H to occur, coupled with a 
constant ∆G value, suggests a compensating change in entropy (from the relationship ∆G 
= ∆H - T∆S).   These results suggest a catalytic strategy to minimize effects on the 
productive ternary complex as compared to the non-productive complexes.  Specifically, 
binding of folate at low salt involves at least one ionic interaction, which is lost by µ = 
0.22.  Loss of the ionic interaction could readily be compensated for by a decreased 
desolvation penalty.  In other words, ions are strongly solvated and to form an ion pair, 
both ions must be desolvated; this process opposes ion pair formation (40).   
Why Does kcat Increase with Increasing Ionic Strength?   
In the kinetic studies with wt and K33M R67 DHFRs, an increase in kcat is 
observed with increasing ionic strength.  This observation is unusual as Park and Raines 
(23) note that in most enzymes, the ground state resembles the transition state and 
changes in ionic interactions typically do not occur.  However these observations are not 
81  
totally unprecedented as increases in kcat have been observed with the NADPH-
cytochrome oxidoreductase-cytochrome c complex (41) as well as the herpes simplex 
virus protease in the presence of increasing ionic strength (42).  The slope of the log-log 
plot of kcat vs. ionic strength (NaCl) in wt R67 DHFR is approximately one.  The 
increased rate could potentially arise if salt increased the N5 pKa of DHF since 
protonated DHF is the productive substrate for R67 DHFR (32).  However Cocco et al., 
(43) find this pKa is not significantly altered by increased ionic strength.  Therefore, an 
increase in the concentration of protonated DHF is probably not responsible for the 
increase in kcat.  A second possibility for the increase in kcat might be due to a larger 
destabilization of the ground state relative to the transition state as µ increases.  This 
would result in a decrease in the activation energy barrier to reach the transition state and 
an increased kcat.  This argument is supported by a slope of 2 for the log-log plots of Kd 
(NADPH) vs. ionic strength contrasted with a subsequent decrease in the slope to 0.6-0.7 for 
the log-log plots of kcat/Km (NADPH) vs. ionic strength.  The data in Figure 8C indicate that 
transition state binding is different than ground state binding and that 1 salt bridge is 
broken as the ground state moves to the transition state.   
Which Residues in R67 DHFR are Involved in Ionic Interactions with the Ligands?   
There are several possible binding models that would allow two ionic interactions 
between R67 DHFR and NADPH.  The first model involves one K32 residue and one 
K33 residue binding to different ionic centers in NADPH.  However, from the crystal 
structure, K32 appears on the binding surface of the active site pore making it more likely 
to be involved in a direct interaction than K33 (2).  In addition, our docking studies 
indicate symmetry related K32 residues are involved in binding both NADPH and DHF, 
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while no direct interactions are predicted for K33 (4).  Further, the salt effect observed 
for the K33M mutant is similar to the salt effect observed in wt R67 DHFR.  In the 
K33M mutant, symmetry related K32 residues are the only positively charged residues 
remaining near the active site pore that possess the potential to be involved in ionic 
interactions with the substrates.  Thus, this model can be eliminated.  A second model 
involves two K32 residues, each from a different monomer of R67 DHFR, contributing 
separate ionic interactions.  K32 (monomer A) could interact with the 2’phosphate while 
K32 (monomer C) would interact with the pyrophosphate bridge (Figure 1).  This model 
appears reasonable and is similar to a docked model of NADPH ((4) and unpublished 
results).  
A model for folate/DHF binding is less clear.  From examination of the crystal 
structure, the two carboxylate groups from the Glu tail of DHF cannot span across the 
end of the pore to interact with two K32 residues from different monomers in R67 
DHFR.  This limitation suggests only one ionic interaction can occur per bound 
DHF/folate.  We were unable to support this model by quantitating the number of 
interactions involved in formation of the 2 folate complex.  Also, the ITC data for folate 
addition to R67 DHFR•NADPH did not quantitate the number of interactions, but this 
interaction must be relatively weak as the ∆H titration is complete by µ=0.22.  Previous 
studies supporting mobility for the Glu tail, include electron density for only the pteridine 
rings in the crystal structure describing bound folate (2), interligand NOE data for the glu 
tail in the R67 DHFR•NADP+•folate complex (44) and numerous positions for the 
PABA-Glu tail of folate in docking studies to generate a reasonable model of the ternary 
complex (4).   
83  
Which Regions of NADPH are Involved in Forming Ionic Contacts with R67 DHFR?  
K32 is conserved in all R-plasmid encoded variants, suggesting it has a functional 
and/or structural role (5).  It has been proposed that K32 interacts with the 2’phosphate of 
NADPH ((4) and Narayana, personal communication).  Kinetic studies using NADH as 
an alternate cofactor reveal a much weaker Km for NADH compared to NADPH at an 
ionic strength of 0.32.  Since these molecules are identical in structure except for the 
substitution of a negatively charged phosphate at the 2’ position with a hydrogen, the 
observed effects on the NADH vs. NADPH Km values are consistent with the 2’ 
phosphate forming an ionic interaction with wt R67 DHFR.  NMR studies (Bob London, 
manuscript submitted) are also consistent with an ionic interaction between K32 and the 
2’phosphate of NADPH.  Yet, two ionic interactions are predicted from the log-log plots 
of Kd (NADPH) and Km (NADPH) vs. ionic strength.  Therefore, there must be an additional 
ionic interaction between the pyrophosphate bridge of NADPH and the enzyme.  This is 
supported by our qualitative observation that the rate increases with increasing salt 
concentration when NADH is used as cofactor.  That a rate increase occurs using either 
NADPH or NADH as cofactor suggests the ionic interaction broken going from the 
ground state to the transition state involves the PPi bridge.   
While the above model is consistent when all the NaCl data are taken into 
account, the observation that NaSCN slope effects on kcat/Km are different indicate some 
degree of anion specificity and suggest the above arguments must remain qualitative.  
While an Ocam’s razor approach supports a simple pattern of binding and catalysis that is 
consistent with the above model, we cannot rule out more unusual effects arising from 
specific ion interactions, as well as the effect of salts on desolvation penalties, the extent 
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of accumulation or exclusion of the solute from the protein surface, the result of charges 
propagating through a hydrophobic interior, long range electrostatic interactions or the 
effect of salt on water properties (34, 35, 45-47).    
What is the Role of K33?   
 
K33 is also conserved in all R-plasmid encoded variants, which suggests that it 
has a functional role as well.  However, its role in binding is not as clear.  The similar 
slopes for salt effects on the wt and K33M mutant enzymes indicate no direct ionic 
interaction between this residue and the ligands.  Yet, ITC reveals this mutant plays a 
minor role in the negative cooperativity during binding of two NADPH molecules.  It 
may be involved in properly positioning K32.  Alternatively, K33, along with K32, may 
enhance the positive electrostatic potential at the active site pore of R67 DHFR to aid in 
binding (4, 48).  
It is interesting to note that the contiguous R31 residue is also conserved, as is 
E75, the sidechain of which is in van der Waals contact with R31.  R29 and E60 are also 
nearby, conserved and in close contact.  A recent report notes that clusters of positively 
charged residues are rare, and may be important in protein structure and function (49).  
Perhaps this charge grouping facilitates NADPH and folate binding. 
  Summary and Conclusions   
DELPHI, a finite Poisson-Boltzmann difference solver, predicts that K32 and K33 
generate a positive electrostatic potential at the active site pore of R67 DHFR (4).  
Numerous enzymes have been proposed to utilize an electrostatic potential to guide 
ligands into the active site where specific interactions can then occur for binding of 
substrate (50-52).  A model for the role of electrostatics in ligand binding and catalysis in 
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R67 DHFR suggests K32 and K33 guide the negatively charged ligands to the active site 
pore by establishing a positive electrostatic potential.  Once the ligands are proximal to 
the active site, symmetry related K32 residues likely contribute direct ionic interactions 
with NADPH and likely DHF (at very low salt).  After formation of the ground state 
complex, at least one ionic interaction breaks, leading to hydride transfer.  This key event 
probably involves loss of an ionic interaction between the enzyme and the pyrophosphate 
bridge of NADPH.  This scenario could permit the ligands to move towards the 
“hourglass” center of the pore, facilitate stacking between the pteridine and nicotinamide 
rings as well as exclude solvent, and ultimately lead to the correct distance and angle for 
hydride transfer.  This unusual mechanism could arise from the need to balance catalysis 
with the constraints of the structure, e.g. the 222 symmetry of the active site pore.  For 
example, if 2 ionic interactions occur between NADPH and symmetry related K32 
residues, then while loss of one interaction (by a mutation) could enhance kcat, the 
concurrent loss of the second symmetry associated interaction would necessarily decrease 
catalytic efficiency (kcat/Km).  Introduction of asymmetry into the active site pore should 
help sort out these various models of catalysis and perhaps lead to enhanced activity. 
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Part III:  Probing the Role of K32 Using Asymmetric Mutations in R67 
Dihydrofolate Reductase 
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Abstract 
Salt effects on the kinetic behavior of wt R67 DHFR have aided in the understanding of 
the catalytic strategy of R67 DHFR.  However, it left one major question unanswered.  
What residue(s) in R67 DHFR participate in ionic contacts with the carboxyl groups in 
the para-aminobenzoic acid tail of DHF (PABA-glu) as well as the oxygen atoms of the 
pyrophosphate bridge and 2' phosphate off the AMP ribose ring of NADPH?  Several 
studies predict that K32 residues are involved; however, destabilization of the R67 DHFR 
homotetramer upon mutation of symmetry related K32 residues, hindered examination of 
this hypothesis directly.  Therefore, the goal of this research is to investigate the 
involvement of K32 in the catalytic mechanism of R67 DHFR using K32M asymmetric 
mutants.  These mutants were generated by linking four gene copies in frame, each of 
which encode a monomer of R67 DHFR (1).  To identify which K32 residues participate 
in binding and/or catalysis, salt effect studies were performed with the K32M asymmetric 
mutants and compared to wt R67 DHFR.  From these studies, it seems the symmetry of 
the R67 DHFR active site plays a major role in ground state binding.  Specifically, 
limiting the number of K32 residues available for participating in ionic interactions, as 
with the K32M: 1+2 and K32M: 1+4 mutants, reduces kcat.  In addition, studies with the 
K32M: 1+3 mutant indicate that formation of the transition state is facilitated by the loss 
of an ionic interaction(s) with DHF.  The K32M: 1+3 mutant possesses two K32 
mutations in one half pore, thus the ability of K32 to participate in an ionic interaction(s) 
with DHF has been eliminated.  Hence, the increase in kcat for this mutant compared to 
Quad3, supports that formation of the transition state is facilitated by the loss of an ionic 
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interaction.  From these studies, several models can be generated to describe a role for 
ionic interactions in the ground state compared to the transition state.      
Introduction 
 R67 dihydrofolate reductase (R67 DHFR) confers resistance to the antibiotic 
trimethoprim (TMP) to its host E.coli.  Thus, this enzyme is clinically important as it 
allows E.coli to sustain life even though the chromosomally encoded DHFR enzyme is 
inhibited by this antibiotic.  R67 DHFR provides resistance because of its sequence and 
structural uniqueness.  Therefore, this is an interesting system to study in order to 
understand the mechanism through which it avoids inhibition.  One of the first research 
questions addressed to more fully understand the catalytic mechanism of R67 DHFR was 
the importance of ionic interactions in ligand binding and catalysis.  While the data from 
this research support a role for ionic interactions in R67 DHFR, a major question 
remains.  Which residues in R67 DHFR are involved in ionic interactions with the 
negatively charged moieties of the substrate and cofactor?  Specifically, these contacts 
include the carboxylate groups of the para-aminobenzoic acid tail (PABA-glu) of DHF 
and the 2'phosphate off the AMP ribose as well as the pyrophosphate bridge of NADPH.   
R67 DHFR possesses an active site made up of four identical monomers.  
However, relatively few residues are involved in formation of the active site and thereby 
participate in catalysis (2).  Only four charged residues are located in the active site.  
These are symmetry related K32 residues, one of which is located in each monomer.  
NMR and docking studies suggest that one role of K32 is an ionic interaction between the 
Nε of K32 and the 2’phosphate off the ribose of the AMP moiety of NADPH.  Briefly, in 
addition to K32 being the only charged residue in the active site, a chemical shift in the 
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resonances associated with the sidechain of K32 was observed upon NADPH binding.  
Also, docking of NADPH into the R67 DHFR•folate complex predicts that K32 is in 
proximity of the 2’phosphate of NADPH, thus allowing an ionic interaction (3, 4).  
Docking studies have also predicted that the Nε of K32 in an adjacent monomer may 
interact with the γ-carboxyl group on the glutamate tail of DHF (3).   Another proposed 
role of K32 is generation of a positive electrostatic potential at the active site pore as 
predicted by the Poisson-Boltzmann difference solver, DELPHI.  K33, located on the 
surface of the enzyme with its side chain pointing out towards solvent, is also predicted to 
be involved in generating the positive electrostatic potential (3).  Positive electrostatic 
potentials have also been predicted to occur not only in other DHFRs, including in  
L. casei and humans (5), but also in acetylcholine esterase, and superoxide dismutase to 
name a few (6, 7).  Electrostatic potentials have been demonstrated to be important for 
attracting ligands to the active site where specific binding interactions can then occur to 
facilitate catalysis (5, 6).    
Although our salt effect studies suggest that K32 is involved in ionic interactions 
with both substrate and cofactor, a direct test of this hypothesis was unattainable in the 
native R67 DHFR system as mutagenesis of K32 results in an inactive, dimeric form of 
the enzyme (Hamilton, masters thesis) (8).  To allow direct examination of the role of this 
residue in binding and catalysis, we utilized a protein that was generated by linking in 
frame four gene copies that code for the 78 amino acid monomer of R67 DHFR  
(Figure 1).  This protein product is active and has a mass four times the molecular mass 
of the monomer.  Hence, each monomer in R67 DHFR corresponds to a domain in this 
protein.  The linker sequence connecting the gene copies corresponds to the natural N- 
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Figure 1.  DNA sequence of the four-gene copy construct of R67 DHFR linked in frame.  
Quad1 is the gene sequence of the construct without unique restriction sites.  Quad2 is the 
construct containing unique restriction enzyme sites.  Quad3 contains both unique 
restriction enzyme sites and an S59A mutation in gene copy1 as well as an H62L 
mutation in gene copy 4 to prevent topology changes.  Asymmetric K32M mutants were 
generated using the Quad3 construct. 
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terminus.  This construct is referred to as Quad1 (9).  Later, four gene copies were again 
linked in frame, but this time unique restriction sites were introduced between each gene 
copy (1).  This construct is called Quad2 (Figure 1).  These restriction sites allow for 
mutagenesis of individual gene copies to create an R67 DHFR mutant protein with 
asymmetric mutations.  Thus, the number of mutations as well as the domain in which the 
mutations occur can be controlled using this system.  This is advantageous since the 
effects of a single, double, or even triple mutant can be evaluated to reveal specificity.    
One initial concern of the quadruplicated system was the ability for changes in topology 
to occur.  In the linked protein, the carboxyl terminus of domain B is equidistant from the 
amino terminus of domains C and D (Figure 2).  This allows for the possibility of domain 
flipping between domains C and D.  Topology changes could thus result in domain B 
being adjacent to domain C or domain D.  In this case it would be impossible to 
distinguish for example, K32M: 1+3 and K32M: 1+4 topologies since K32M: 1+3 
contains a K32M mutation in domain C while K32M: 1+4 contains a K32M mutation in 
domain D.  Thus, assessing effects of mutations in these domains would be difficult due 
to averaging of kinetic effects resulting from possible orientations.  To prevent domain 
flipping, an H362L mutation (gene copy 4) and an S59A mutation  (gene copy 1) have 
been introduced into Quad2 to constrain the topology of the tethered R67 DHFR protein.  
This protein is called Quad3 (1) (Figures 1 and 2).  This strategy was based on previous 
experiments illustrating that a 1:1 mixture of S59 mutants (result in the formation of 
inactive dimers) and H62L mutants (also result in inactive dimers) results in the 
formation of an active hetero-tetramer of R67 DHFR (10).  Mutagenesis of these residues 
makes it unfavorable for topology switching to occur, as it would result in the pairing of a  
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Figure 2.  Possible topologies of Quad3.  S59A and H62L mutations in domains 1 and 4 
prevent topology changes in the quadruplicated R67 DHFR protein.  If domain flipping 
occurs, S59 in domain 2 would interact with the hydrophobic H62L residue in domain 4 
and S59A in domain 1 would interact with the polar H62 residue in domain 3. 
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hydrophobic alanine residue (S59A) with a polar histidine (H62) as well as the paring of 
a hydrophobic leucine (H362L) with a polar serine (S59) (1) (Figure 2).  Using this 
quadruplicated R67 DHFR gene system, K32M double mutants have been constructed 
and the role of asymmetric K32 residues in ionic interactions with NADPH and DHF has 
been assessed. 
The symmetry of the R67 DHFR active site was utilized to construct asymmetric 
K32M mutants.  Mutations in gene copies 2 and 4 should be equivalent to mutations in 
gene copies 1 and 3 just as mutations in gene copies 2 and 3 are equivalent to mutations 
in gene copies 1 and 4.  Due to this equivalence and for comparative purposes, the K32M 
mutants will be named such that gene copy 1 is a reference.  Hence, the asymmetric 
double K32 mutants will be referred to as K32M: 1+2, K32M: 1+3, and K32M: 1+4.  To 
minimize confusion, we have adopted the following nomenclature.  The Quad3 construct 
containing a single K32M mutation in the second gene copy is referred to as K32M: 1.  
K32M: 1+2 contains mutations in gene copies 1 and 2.  These mutations are located at 
positions corresponding to the monomer-monomer interface in wt R67 DHFR.  K32M: 
1+3 contains two K32M mutations located in domains 2 and 4, which reside in the same 
half of the pore across from one another.  K32M: 1+4 contains mutations in domains 2 
and 3, which reside along the dimer-dimer interface.  Two different diagrams showing 
the various asymmetric mutations are illustrated in Figures 3 and 4.  Due to structural 
problems resulting from the K32M substitution in the homotetramer, precautions were 
taken in generating the K32M: 1+4 mutant, which possesses two mutations at the same 
interface.  Since the symmetry of the active site of R67 DHFR dictates that all double 
mutants should be equivalent, mutations in gene copies 2 and 3 should be equivalent to  
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Figure 3.  The location of asymmetric K32M mutations depicted in the ribbon structure 
of wt R67 DHFR.  Each monomer in wt R67 DHFR corresponds to a domain in Quad3.  
Domain 1 is colored red, domain 2 is yellow, domain 3 is green, and domain 4 is purple.  
The expected positions of the mutations are shown in white whereas wild-type K32 
residues are indicated in color.  Figures on the left hand side show the homotetramer 
looking end on with the active site pore in the center.  Figures on the right hand side are 
related to the figures on the left by a 90° rotation along the y-axis.  (A).  Ribbon diagram 
illustrating the positions of K32 in each domain in CPK.  (B).  The K32M: 1+2 mutant 
possesses mutations that are across the pore from one another located at the monomer-
monomer interface (red and yellow).  (C).  The K32M1+3 mutant contains mutations 
located on the same side of the pore located above and below the monomer-monomer 
interface (red and purple).  (D).  The K32M 1+4 mutant possesses mutations along the 
dimer-dimer interface (red and green).
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Figure 4.  Location of wt K32 residues in the active site of R67 DHFR.  The wt K32 
residues are depicted in red in reference to the sphere cluster representation of the active 
site.  The NADPH position in the active site is predicted from docking studies (3) and is 
depicted in green.  The top scoring folate conformer from docking studies (3) is depicted 
in yellow.  (A) Panel A illustrates the location of the four K32 residues in the active site.   
(B) Panel B illustrates the location of the wt K32 residues in red in the K32M: 1+2 
mutant.  (C) Panel C depicts the positions of the wt K32 residues in the K32M: 1+3 
mutant.  (D) Panel D shows the location of wt K32 residues in the K32M: 1+4 mutant. 
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mutations in gene copies 1 and 4.  With this in mind, K32M: 1+4 was generated by 
mutating gene copies 2 and 3.  These domains were chosen since they are tethered by a 
linker sequence, as opposed to gene copies 1 and 4, which are not linked.  Therefore, 
large structural perturbations should be minimized in this construct. 
The focus of this research is to examine the role of K32 in both ground state and 
transition state binding in R67 DHFR.  Kinetic characterization of three K32 asymmetric 
double mutants has been performed.  In addition, the salt sensitivity of each of the 
various kinetic parameters has been assessed.  From these studies, a model for the role of 
K32 in binding and catalysis has been proposed.    
Materials and Methods 
Construction of Quad3 and Asymmetric Mutants  
To generate Quad3, four plasmids containing a single copy of the R67 DHFR 
gene coding for monomeric R67 DHFR, each flanked by unique restriction enzyme sites, 
were created.  These genes were then ligated together.  For example, one plasmid 
containing the R67 DHFR gene possesses Bcl1 and EcoRV sites while another plasmid 
contains the R67 DHFR gene flanked by EcoRV and KpnI.  In order to generate an 
asymmetric mutation, site-directed mutagenesis is performed using one plasmid 
containing a single copy of the R67 DHFR gene.  This mutated plasmid, as well as 
Quad3, is then digested with the appropriate restriction enzymes.  Digested DNA is 
separated electrophoretically and the mutated DNA is ligated into the Quad3 construct in 
place of the non-mutated wt R67 DHFR gene sequence (1).  The oligonucleotide primer 
for the coding strand used to generate mutations in different gene copies of Quad3 
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corresponding to amino acid position 32 using the Stratagene QuikChange Mutagenesis 
Kit was: 
5’GGGTGACCGCGTACGTATGAAATCCGGAGCCGCC3’ (K32M) 
All mutants were verified by automated fluorescence DNA sequencing at the University 
of Tennessee DNA Sequencing Facility using an ABIPRISM Dye Terminator Cycle 
Sequencing Kit from Perkin-Elmer. 
Growth and Purification  
E.coli STBLII cells containing the plasmid carrying the desired mutations were 
grown in TB media (11) at 30°C for 60 hours in the presence of 200ug/ml AMP only 
since introduction of TMP into the growth media results in random mutations within the 
genes sequence.  STBLII cells were used since they are a Rec A- strain and therefore 
cannot undergo recombination.  An aliquot of each of the 12 liters of the  
K32M: 1+3 and K32M: 1+4 mutants were minipreped and sent for DNA sequencing to 
verify the stability of these mutants over the 60 hour growth period.  Cells were lysed 
using sonication and the crude extract was precipitated with 55% ammonium sulfate.  
Mutant protein was purified using a series of chromatographic steps including: DEAE-
Fractogel and High-Q anion exchange columns as well as a G-75 Superdex size exclusion 
column.  During the purification process, the proteins were maintained in buffer solutions 
containing 0.1g/L polyethylene glycol (PEG) since this addition minimizes aggregation 
and leads to higher protein yields.  Other reagents were also assayed for their ability to 
reduce aggregation of the mutant proteins including ethanol, Brij, and glycerol.  
However, this concentration of PEG seemed to be the most effective at minimizing 
aggregation.     
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pH titrations  
 
 To evaluate the effects of salt on the stability of Quad3, pH titrations were 
performed in the presence of various concentrations of NaCl.  These experiments monitor 
the environment of W38 residues, which reside at the dimer-dimer interface.  At pH 8, 
these residues are buried and exhibit a different fluorescence property than when they are 
exposed to solvent at pH 5 (12).  The change in environment of the tryptophan residues is 
linked to the protonation of H62 residues present at the dimer-dimer interface.  As the 
H62 residues become protonated, there is a loss of the tetrameric form of wt R67 DHFR 
(13).  While Quad3 cannot dissociate due to the linker sequences between each gene 
copy, it can undergo a transition from a "closed" form (active conformation) to an "open" 
form (inactive), which can be monitored using this technique.  The averaged emission 
wavelength <λ>, for each emission spectrum was calculated using  
<λ>=Σ (Iiλi)/Σ(Ii)           
(1) 
where I is intensity, and λ is the wavelength (14).  The fluorescence data were fit to using 
a nonlinear regression subroutine of the Statistical Analysis Systems package (SAS, 
Cary, NC) to obtain pKa values for each salt concentration tested.  Fitting to the following 
equation normalized the data:  
Fapp=(Yobs – YpH8)/(YpH4 – YpH8) 
(2) 
where Fapp is a fractional value between 0 and 1, and Yobs, YpH8, and YpH4 are the optical 
values associated with the observed pH and the pH limits 8 and 4, respectively. 
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Circular Dichroism  
Circular dichroism (CD) spectra were recorded at 22°C in 10 mM potassium 
phosphate buffer, pH 5 and 8 with 10 µM wild type Quad3, K32M: 1+2, K32M: 1+3, and 
K32M: 1+4 mutant R67 DHFRs using an Aviv Model 202 series circular dichroism 
spectrometer.  Data were collected from 190 nm to 300 nm using a cuvette pathlength of 
1.0 mm.  Spectra were generated for each sample using 2 nm steps with an integration 
time of 2 seconds.  A buffer baseline was subtracted from each scan and data were 
subsequently converted to molar ellipticity (θ) using 108 g/mole as the mean residue 
molecular weight. 
Steady-State Kinetics with Mutants 
Steady-state kinetics of each mutant were monitored using a Perkin-Elmer λ3a 
spectrophotometer interfaced to an IBM PS2 computer using the software program UVS 
(15).  Experiments were performed at 30°C in either MTH buffer or TE buffer in the 
presence of various concentrations of NaCl to adjust the ionic strength, at pH 7.  Ligands 
were diluted in TE buffer (without NaCl) for each experiment to minimize degradation, 
particularly DHF.  Five subsaturating concentrations of NADPH and DHF were used to 
measure activity.  Data were fit using the non-linear SAS program version 8.2, describing 
the bi-substrate kinetic reaction of R67 DHFR (1).  The extinction coefficient for the R67 
DHFR reaction at 340 nm is 12,300 L mol-1cm-1 (16).  Ligand concentrations used for 
fitting were calculated using the extinction coefficient of 28,000 mol-1 cm-1 at 282 nm for 
DHF (17) and 6220 L mol-1cm-1 at 340 nm for NADPH (18).  Kinetics with the  
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K32M: 1+3 mutant were obtained at 360 nm to more accurately assess the Km values. 
The extinction coefficient for the DHFR reaction is 5020 L mol-1cm-1 at this wavelength.  
Extinction coefficients for NADPH and DHF are 4020 L mol-1cm-1 and 2630 L mol-1cm-1 
at 360 nm.     
Results  
 
Structural Effects of Salt Concentration 
 
pH titrations with Quad3  
 
 pH titrations were performed with Quad3 in MTH buffer with 0M, 0.15M, 0.5M, 
and 0.75M NaCl (Figure 5).  The data were fit and the corresponding pKa values are 
indicated in Table 1.  It is apparent from the fits that addition of salt slightly stabilizes the 
protein.  However, there is not a significant difference in the titrations with Quad3 in the 
presence of different salt concentrations around pH 7, where the majority of experiments 
are performed.        
Structural Effects of Mutations 
Circular Dichroism of K32M Double Mutants 
 Circular dichroism spectra were generated for each of the K32M double mutants 
at pHs 8 and 5.  Comparison of the spectra for each mutant to that of Quad3 reveals that 
the K32M: 1+2 and K32M: 1+3 substitutions do not result in a significant change in the 
secondary structural content of the mutant proteins (Figure 6).  Therefore, kinetic changes 
observed with these mutants most likely do not result from a large conformational change 
at the level of secondary structure.  The spectra for the K32M: 1+4 does reveal that there 
are some differences in the secondary structural content between this mutant and Quad3, 
particularly at pH 8.  Since this mutant possesses 2 K32M mutations at that correspond to 
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Figure 5.  Fapp curves generated from pH titration experiments with Quad3 in the 
presence of various concentrations of NaCl to examine salt effects on the “closed” to 
“open” forms.  Titration experiments were performed in the presence of  
MTH (?,         ), MTH containing 0.2M NaCl (    ,        ), MTH containing 0.5M NaCl 
(?,         ), and MTH containing 0.75M NaCl (?,        ).    
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Table 1.  Salt effects on the pKa of Quad3.  
pH titration experiments were carried out in 
MTH buffer over the pH ranges of 8 to 4, in 
the presence of NaCl to adjust the ionic 
strength. 
Salt Concentration pKa value 
 
0 5.9 ± 0.01 
 
0.25 5.95 ± 0.01 
 
0.5 5.7 ± 0.01 
 
0.75 5.6 ± 0.02 
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Figure 6.  Circular dichroism spectra for Quad3 and each of the K32M double mutants at 
pH 8 and pH 5.  (A) Panel A depicts the spectra generated at pH 8 for Quad3 (      ), 
K32M: 1+2 (      ), K32M: 1+3 (      ), and K32M: 1+4 (      ).  (B) Panel B illustrates the 
spectra generated for these proteins at pH 5.  
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the dimer-dimer interface in wt R67 DHFR, some perturbation may exist.  This particular 
construct was however generated to minimize any effects of the substitution by mutating  
gene copies 2 and 3, as opposed to 1 and 4.  Gene copies 2 and 3 correspond to domains 
in the protein that are tethered by a linker sequence.  Thus, the tether is expected to 
reduce changes in the “closed” vs. “open” forms of Quad3 with respect to this mutant. 
        
Steady-StateKinetics with K32M Double Mutants 
K32M: 1+2   
This R67 DHFR mutant protein contains K32M mutations in domains 1 and 2 and 
has wild-type K32 residues in domains 3 and 4 (Figures 3 and 4).  This results in one 
wild-type site for binding either cofactor or substrate in each half of the pore.  The kinetic 
data for the K32M: 1+2 mutant indicate that NADPH binding is 4 fold weaker, DHF 
binding is 2 fold weaker, and kcat is decreased 4 fold (Table 2).   
In order to evaluate the number of ionic interactions with each ligand as well as 
the involvement of K32 in these interactions, salt effects on this mutant were analyzed.  
These studies were performed in TE buffer, pH 7 in the presence of various 
concentrations of NaCl to adjust the ionic strength.  Both Km (NADPH) and Km (DHF) increase 
with increasing ionic strength (Tables 3 and 4).  A salt concentration dependence of these 
parameters reflects ionic interactions exist between this mutant and substrate as well as 
with cofactor.  However, salt has only a small effect on kcat (Figure 7).   
K32M: 1+4 
 Steady-state kinetics were also performed with the K32M: 1+4 mutant, which 
possesses mutations in gene copies 2 and 3, and reveal that this mutant binds NADPH  
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Table 2.  Steady-state kinetic values for the K32M asymmetric double mutants in 
MTH buffer, pH 7 at 30°C.  Data were fit using the non-linear SAS program 
describing the bi-substrate kinetics of the R67 DHFR reaction. 
 
Quad Species Km (NADPH)  
(µM) 
Km (DHF)  
(µM) 
kcat (s-1) 
 
Quad 3a 
 
4.4 ± 0.4 6.7 ± 0.4 0.8 ± 0.02 
K32M 1+2 
 
17.1 ± 0.09 14.4 ± 0.06 0.2 ± 0.01 
K32M 1+3 ≥ 160  ≥ 330  ≥ 3.6  
 
K32M 1+4 5.4 ± 0.2 10.5 ± 0.3 0.1 ± 0.01 
 
 
 
 
a from (1). 
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Table 3.  Steady-state kinetic values for the K32M: 1+2 mutant in TE buffer 
pH 7 with various concentrations of NaCl added to adjust the ionic strength.   
Salt 
Concentration 
(Ionic 
Strength) 
Km (NADPH) 
 (µM) 
Km (DHF) 
 (µM) 
kcat (s-1) 
 
 
0.03 
(µ=0.05) 
 
8 ± 0.3 17 ± 0.8 0.33 ± 0.01 
 
0.05 
(µ=0.07) 
 
11.4 ± 0.5 14.6 ± 0.5 0.30 ± 0.02 
 
0.08 
(µ=0.1) 
 
11.2 ± 3.0 23.2 ± 7.0 0.31 ± 0.02 
 
0.1 
(µ=0.12) 
 
15.9 ± 0.5 34.2 ± 0.5 0.33 ± 0.02 
 
0.132 
(µ=0.15) 
 
30.1 ± 1.8 51.1 ± 2.6 0.4 ± 0.04 
 
0.132 
(µ=0.15) 
 
31.1 ± 2.5 27.7 ± 1.5 0.37 ± 0.02 
 
0.16 
(µ=0.18) 
 
30.6 ± 1.1 60.6 ± 3.1 0.4 ± 0.01 
 
0.2 
(µ=0.22) 
 
60.8 ± 2.9 63.6 ± 2.4 0.41 ± 0.03 
 
0.2 
(µ=0.22) 
45 ± 1.9 43 ± 1.7 0.43 ± 0.01 
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Table 4.  Slopes of log-log plots of various kinetic parameters vs. ionic strength 
for the K32M: 1+2 and K32M: 1+4 mutants compared to wt R67 DHFR. 
DHFR 
Species 
Slope 
kcat/Km 
(NADPH) 
Slope 
kcat/Km 
(DHF) 
Slope kcat Slope  
Km (NADPH) 
Slope  
Km (DHF) 
wt R67 
DHFR 
 
0.6 ± 0.09  0.9 ± 0.03 0.8 ± 0.03 1.5 ± 0.1 1.8 ± 0.2 
K32M: 1+2 1.1 ± 0.13 0.72 ± 0.16 0.2 ± 0.05 1.3 ± 0.02 0.9 ± 0.02 
 
K32M: 1+4 1.1 ± 0.2 1.2 ± 0.2 0.2 ± 0.02 1.3 ± 0.06 1.3 ± 0.2 
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Figure 7.  Log-log plots of each kinetic parameter vs. ionic strength for the 
K32M: 1+2 mutant.  There is a linear correlation between each parameter and 
ionic strength.  Steady-state kinetics were performed in TE buffer pH 7 at 
30°C. 
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with the same affinity as Quad3 while there is a 1.6 fold decrease in the affinity 
for DHF.  The Km (NADPH) is 5.4 ± 0.2 µM and the Km (DHF) is 10.5 ± 0.3 µM 
compared to 4.4 ± 0.4 µM and 6.7 ± 0.4 µM for Quad3 (Table 2).  However, the 
kcat is decreased 8-fold by this mutation, 0.1 ± 0.01 s-1 compared to 0.8 ± 0.02 s-1 
for Quad 3. 
The salt concentration dependence of the Km values for cofactor and substrate 
were evaluated for this mutant (Figure 8).  Both Km (NADPH) and Km (DHF) are salt sensitive 
indicating ionic interactions are present in this mutant (Tables 4 and 5).  However, kcat is 
only minimally affected by salt concentration. 
K32M: 1+3  
 The K32M: 1+3 mutant protein possesses mutations in gene copies 2 and 4, 
which are equivalent to domains 1 and 3 in Quad3.  This mutation results in one half of 
the pore containing two K32M mutations, leaving the other half of the pore wild type 
(Figures 3 and 4).    The Km (NADPH) for this mutant is ≥160 µΜ and the Km (DHF) is ≥ 330 
µM compared to 4.4 ± 0.4 µM and 6.7 ± 0.4 µM, respectively for Quad3 (Table 2 and 
Figure 9) (1).  The kcat is increased ≥ 3.6 fold compared to Quad3.    
Due to the extreme elevation in the Km values for both substrate and cofactor 
resulting from this mutational configuration, the salt sensitivity of these kinetic 
parameters were not attainable.  Changing assay wavelengths from 340 nm to 360 nm 
allows higher concentrations of DHF and NADPH to be used for kinetic analysis, since 
360 nm lies slightly off the peak absorbance for these ligands.  Therefore, the total 
absorbance is better maintained within the limits of the spectrophotometer.  Even this  
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Figure 8.  Log-log plots of the kinetic parameters for the K32M: 1+4 mutant vs. ionic 
strength.  Kinetic experiments were performed at 30° C in TE buffer, pH 7 with various 
concentrations of NaCl to adjust the ionic strength.     
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Table 5.  Kinetic values for salt effects on the K32M: 1+4 mutant in the presence of 
TE, pH 7 with NaCl added to adjust the ionic strength. 
Salt Concentration 
(Ionic Strength) 
 
Km (NADPH) 
(µM) 
Km (DHF) 
(µM) 
kcat 
(s-1) 
0.08 
(µ=0.1) 
 
7.2  ± 0.2 
 
12.6 ± 0.4 0.19 ± 0.01 
0.13 
(µ=0.15) 
 
12.2 ± 0.5 27.7 ± 1.0 0.30 ± 0.01 
0.2 
(µ=0.18) 
 
 22.4 ± 0.08 
 
39.9 ± 1.4 0.22 ± 0.01 
0.23 
(µ=0.25) 
 
23.7 ± 1.1 39.1 ± 2.0 0.22 ± 0.01 
0.28 
(µ=0.3) 
 
28.7 ± 1.6 48.8 ± 4.0 0.19 ± 0.01 
0.28 
(µ=0.3) 
32.7 ± 1.7 76.6 ± 4.9 0.32 ± 0.01 
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Figure 9.  Illustration of SAS fit to K32M: 1+3 kinetic data in MTH buffer, pH 7 at 
30°C.  From the plot, it is apparent that there is not a plateau in the rate of the reaction 
with increasing DHF concentration.  A plateau is also absent when the rate of the reaction 
is plotted vs. NADPH concentration.  The Km (DHF) values are sufficiently high that they 
cannot be accurately obtained.  To attempt to bracket Km (DHF), concentrations of DHF 
used for these studies were extremely high.  Thus, NADPH concentrations had to be kept 
to a minimum to monitor the reaction within the limits of the spectrophotometer. 
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approach however, was not sufficient to bracket Km (DHF).  Steady-state kinetics were also 
attempted in TE buffer, pH 7 with 0.01M NaCl (µ = 0.03).  This buffer was used since it  
has a lower ionic strength than MTH buffer.  Unfortunately, the Km (DHF) was still 
unattainable, as Km (DHF) was ≥ 490 µM,  Km (NADPH) was ≥ 60µM, and kcat was 
 ≥ 4.9 s-1.          
Discussion 
Previous docking, NMR, and salt effect studies have been used to create a model 
for both NADPH and DHF binding in the pore of R67 DHFR (3, 19, 20).  These studies 
support a model where ionic contacts are involved in NADPH and DHF binding in the 
ground state as well as the transition state.  However, the salt effect studies on kcat and 
kcat/Km (NADPH) and kcat/Km (DHF) in wt R67 DHFR indicate that the loss of an ionic 
interaction facilitates formation of the transition state and thus product formation (8).  
While salt effects were used in the previous study with wt and K33M DHFRs to ascertain 
the number of ionic contacts involved in ligand binding and catalysis (8), a more 
qualitative approach is being used in the current study to evaluate the importance of ionic 
interactions.  This approach has been adopted due mainly to the complication of 
deciphering the exact number of ionic interactions from the salt effect data on the K32M 
double mutants compared to those of wt and K33M DHFRs.  However, the overall goal 
of this project remains, to identify residue(s) involved in the ionic contacts with cofactor 
and substrate to generate a model for the involvement of ionic interactions in the 
mechanism for R67 DHFR.     
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DHF Binding 
Insight into the role of K32 in interactions with the substrate have progressed 
through studies with the K32M: 1+3 mutant.  The large effects on DHF binding in this 
mutant reveal that K32 residues must be involved in interactions with substrate.  While 
salt effects were not directly examined for the K32M: 1+3 mutant, these contact(s) are 
most likely ionic in nature.  This hypothesis arises from several pieces of data.  First, wt 
R67 DHFR reveals that Km (DHF) is salt sensitive (8).   In addition, a salt sensitivity for 
folate binding (similar to DHF with the exception of a double bond between C7and C8) 
has been directly monitored in the ternary complex of R67 DHFR•NADPH•folate using 
ITC (8).   
An increase in kcat is observed in the presence of increasing salt for wt R67 DHFR 
and appears to arise in the K32M: 1+3 mutant as well, as kcat is ≥ 4.5-fold higher than that 
of Quad3.  Thus, this mutant which has lost any potential for an ionic contact with DHF 
due to the substitution of both K32 residues in one half pore, mimics the effects of salt on 
kcat for wt R67 DHFR.  These data suggest that the loss of an ionic interaction(s) with 
DHF facilitates formation of the transition state.       
A general model for DHF binding in R67 DHFR can be generated using the 
information from the K32M double mutant series as well as previous docking, NMR, 
ITC, and salt effect studies (3, 4, 8).  Once the R67 DHFR•NADPH complex has been 
formed, DHF binds in the active site.  The PABA-glu tail of DHF may form an ionic 
interaction(s) with K32 in either subunit comprising the same half pore (Figure 10).  This 
could allow for a favorable enthalpy for binding due to the formation of direct contacts as 
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Figure 10.  Multiple conformations of the PABA-glu tail of folate predicted from 
docking studies (3).  A representation of the active site pore of R67 DHFR is illustrated 
by the sphere cluster, with the position of K32 residues in the active site pore indicated in 
red.  The NADPH position in the active site is predicted by docking studies and is 
depicted in green.  Top scoring folate conformers from docking studies are illustrated in 
yellow.  While the position of the pteridine ring of folate is similar in these docked 
conformers, the para-amino benzoic acid tail (PABA-glu) is predicted to be in multiple 
orientations.  Folate and DHF both possess the PABA-glu tail.  Thus, DHF binding in the 
active site may utilize multiple conformations of the tail to participate in contacts with 
K32 residues in one half of the pore.  
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well as reduce the entropic penalty by allowing movement with respect to the tail of 
DHF.  One way for this type of binding to be achieved is through water mediated ionic 
interactions.  Thus each K32 residue in one half pore may be solvated and thus indirectly 
interact with the α and/or γ carboxylate groups on the tail of DHF.  Thus, the tail of DHF  
is likely bound in a manner that is "balanced".  This describes ground state binding with 
respect to DHF.  On the other hand, when the glutamate tail of DHF is "pushed" or 
"pulled" to the binding extremes in the K32M: 1+2 and K32M: 1+4 double mutants, the 
catalytic rate suffers.       
NADPH Binding 
We have previously interpreted salt effects on wt R67 DHFR to indicate 2 ionic 
interactions are involved in binding of NADPH in the ground state, while one ionic 
interaction is lost to form the transition state.  The effects of asymmetric K32M mutants 
have been studied to examine more closely the role of K32 in ionic interaction(s) with 
NADPH.  The K32M: 1+2 mutant possesses one mutation in each half pore.  The result 
of this mutation is to decrease the salt effect on kcat while both Km (NADPH) and Km (DHF) 
exhibit a salt effect.  This behavior is also seen in the K32M: 1+4 mutant which also 
possesses a single mutation in each half pore; however, in this mutant, both mutations are 
at the same interface.  The Km (NADPH) for the K32M: 1+2 mutant is approximately 3-fold 
weaker than seen in Quad3.  On the other hand, the Km (NADPH) for K32M: 1+4 mutant 
possesses a Km (NADPH) that is approximately the same as that of Quad3.  While the role of 
K32 in ionic contacts with NADPH is less clear than with DHF, these data sheds some 
light on NADPH binding in the active site pore of R67 DHFR.  First, the apparent salt 
sensitivity of Km (NADPH) and kcat/Km (NADPH) for these mutants, as well as a 50-fold effect 
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on kcat/Km in the presence of NADH compared to NADPH for wt R67 DHFR, suggest 
that at least one ionic interaction may occur between K32 and NADPH.  Second, there 
may be a slight preference for NADPH binding in the active site pore for the K32M: 1+2 
mutant configuration as it displays a 3-fold decrease in affinity compared to the K32M: 
1+4 mutant which displays a binding affinity similar to Quad3.   
The kcat for both of these mutants is lower than that of Quad3.  This could result 
from the decrease in wt K32 residues available for binding NADPH or DHF in each half 
pore.   This may in turn effect ground state binding, leading to a decrease in the number 
of possible binding modes available to reach the transition state and thereby reduce kcat.  
In addition, only a small effect on the slope of kcat in the presence of salt is observed for 
these mutants.  If this small effect corresponds to the bottom of a titration curve, then 
higher concentrations of salt may be required to observe an increase in kcat.  Thus, the 
range of salt concentration used for these experiments may not be sufficient to observe a 
salt effect on kcat.  This hypothesis can be examined by performing kinetics at higher salt 
concentrations.        
The K32M: 1+3 mutant possesses mutations in one half of the pore leaving the 
other half of the pore containing two wild-type K32 residues (Figures 3 and 4).  
According to the binding scheme for R67 DHFR (21), NADPH binding occurs first, so 
we would predict that NADPH would preferentially bind in the wt half of the pore.  In 
this case, we would expect that Km (NADPH) is unaffected in this mutant, while DHF would 
be forced to bind to the mutant half of the pore, resulting in a large effect on Km (DHF) if 
K32 is indeed involved in ionic interaction(s) (direct or indirect) with DHF.  This type of 
pattern has been previously observed in the Y69F double mutant series (Stinnett, 
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unpublished results).  The results of the kinetics for this K32M: 1+3 mutant are therefore 
surprising since the Km (NADPH) is affected as well as the Km (DHF).   One possibility for this 
result is a change in the order of binding.  This seems unlikely since the affinity for 
NADPH is at least 2 times greater than for DHF in this mutant.  Another possibility is the 
mutation results in a reduction of the positive electrostatic potential at the active site, 
which concomitantly causes a decrease in the affinity for NADPH.  This seems unlikely 
as both of these mutations are on the same half of the pore with their sidechains pointing 
in the same direction in the active site.  This should cause the electrostatic potential to be 
diminished on the face of the pore possessing the mutations.  The electrostatic potential 
on the face without mutations is predicted to remain unaffected; thereby the affinity for 
NADPH is expected to be similar to that of the wild-type enzyme.  A third, more likely 
possibility, is that the Km (NADPH) is kinetic and does not reflect the true Kd (NADPH).  This 
can occur if rate constants other than enzyme-substrate are included in the Km (NADPH)(22).  
This hypothesis still needs to be tested.  
 This research sheds light on the binding of NADPH in the active site of R67 
DHFR and aids in the generation of models to describe the origin of the two ionic 
contacts involved in NADPH binding.  One possible model includes 2 K32 residues 
involved in ionic contacts with the 2' phosphate and the pyrophosphate bridge of NADPH 
and the α and γ carboxylate groups on the DHF tail.  While there is a salt effect for both 
NADPH and DHF binding in the K32 double mutants, the exact number of interactions 
cannot be interpreted confidently.  However comparison of the slopes for Km (NADPH), kcat, 
and kcat/Km (NADPH) vs. ionic strength for the K32M double mutants and wt and K33M 
DHFRs, reveal that the largest effects are upon the slopes for kcat vs. ionic strength.  
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Thus, the absence of a significant difference in the Km (NADPH) for the K32M: 1+2 and 
K32M: 1+4 mutants as well as the negligible differences in the slopes of the Km (NADPH) 
vs. ionic strength plots for these mutants refutes a model involving 2 K32 residues 
interacting with both charged moieties on NADPH.  A second model includes one K32 
residue and a cluster of positively charged residues on the surface of R67 DHFR.  In this 
model, there is a direct ionic contact between K32 and NADPH and an indirect long-
range ionic interaction contributed by a charged cluster located on the surface of R67 
DHFR.  Interestingly, R67 DHFR possesses a cluster of charged residues on its surface, 
which are conserved.  This includes residues R31, E60, R29 and E75.  Long-range 
electrostatic effects have been implicated in ligand binding and catalysis through their 
demonstrated importance in protein stability, protein-protein interactions, and effects on 
pKa values of active site residues (23).  A third model involves two K32 residues, one in 
each half of the pore making at least one ionic contact with NADPH and at least one 
ionic contact with DHF in the ground state.  To reach the transition state, one or more of 
these interactions are broken, thus facilitating catalysis.  
Summary and Conclusions    
 Data from the K32M asymmetric mutants reveal that R67 DHFR may utilize 
symmetry to achieve binding in the ground state as well as facilitate catalysis.  Symmetry 
of the active site may thus provide equivalent binding sites.  Thus, removing two K32 
residues from one half pore, as in the K32M: 1+3 mutant, results in a large penalty in 
ground state binding.  However, this is partially compensated for by an increase in kcat.  
The value of 3.6 s-1 may reflect an upper limit for kcat that would correspond to a salt 
independent value.  However, since the Glu tail of DHF still possesses a charge, this 
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condition does not quite mimic the salt conditions.  Therefore, the intrinsic kcat could be 
different and perhaps higher.  This data suggests that ionic contacts, while important for 
ground state binding, must be broken to facilitate formation of the transition state.  
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Introduction 
 R67 dihydrofolate reductase (DHFR) is a homotetrameric enzyme that possesses 
222 symmetry in the active site pore (1).  NMR and docking studies predict that ionic 
interactions are involved in cofactor and substrate binding (2, 3).  Yet, only one charged 
residue occurs in each monomer which projects into the active site and thus possesses the 
potential to participate in ionic contacts, K32.  The only other charged residue near the 
active site is K33, yet its side chain points away from the active site out into solvent (1).  
Both K32 and K33 have also been predicted by DELPHI, a finite Poisson-Boltzmann 
difference solver, to generate a positive electrostatic potential at the active site pore (3, 
4).  This positive potential may be important for attracting the negatively charged ligands, 
NADPH and DHF, to the pore of R67 DHFR thereby facilitating catalysis.     
Based on these preliminary findings, the importance of ionic interactions in R67 
DHFR was experimentally tested. The goal of this research was to aid in the 
understanding of the role of ionic interactions in the ground and transition state binding.  
This final chapter summarizes these findings as well as provides a general model for the 
overall contribution of ionic interactions to binding and catalysis in the R67 DHFR 
reaction mechanism.  
Proposed Ionic Interactions with NADPH and DHF  
NADPH and DHF both possess net negative charges.  The net negative charge of 
NADPH is –3, which arises from the oxygen atoms of the pyrophosphate bridge and the 
oxygen atoms of the 2’phosphate off the hydroxyl of the ribose attached to the adenine 
ring.  DHF possesses a net charge of –2 resulting from negatively charged α and γ 
carboxylate groups on the glutamate residue at the end of the para-aminobenzoic acid tail 
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(PABA-glu).  In order to investigate the prediction that the negatively charges moieties of 
NADPH and DHF are important for binding to R67 DHFR, a combination of 
mutagenesis, kinetics, fluorescence quenching, and isothermal titration calorimetry 
approaches have been performed.     
Number of Ionic Interactions Involved in Ligand Binding 
Salt sensitivities were previously recorded for kcat/Km (NADPH), kcat/Km (DHF), and kcat 
for both wt and K33M DHFRs.  While these data support a role for ionic contacts in 
ligand binding as well as in catalysis, the number of ionic interactions involved in each of 
these processes was still an open question.  To evaluate this, slopes of log-log plots of Kd, 
Km, kcat, and kcat/Km vs. ionic strength were measured (5).  This approach was first 
reported in 1976 by Record et al., using DNA binding to proteins (6).  More recently, this 
has been described by Park and Raines using Ribonuclease A binding to DNA (7).  Salt 
effects on Kd1 (NADPH) were investigated using both ITC and fluorescence quenching.  
Slopes of log-log plots of Kd1 (NADPH) vs. ionic strength were 2.  However, Kd (DHF) vs. 
ionic strength could not be obtained using these techniques.  Additionally, slopes of the 
log-log plots of Km (DHF) vs. ionic strength and Km (NADPH) were 2 (5).  While we were 
skeptical of relying on the slopes of the Km vs. ionic strength plots as Kms can reflect rate 
constants other than the formation of the enzyme-substrate complex (8), agreement 
between the slopes of the log-log plots for Kd (NADPH) and Km (NADPH) led us to consider the 
simple interpretation that two ionic interactions were involved in NADPH binding in the 
2NADPH complex as well as the ternary E•NADPH•DHF complex.  In retrospect, the 
salt sensitivity of Kd (NADPH) monitors the formation of the binary complex and does not 
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necessarily reflect the salt sensitivity of the productive ternary complex.  Due to this 
complication, we will consider what possible models remain to explain the data.   
Salt effects on folate in the ternary E•NADPH•folate complex were investigated 
(folate is similar in structure to DHF with the exception of a double bond between C7 and 
C8).  The data reveal that folate binding in the ternary complex is salt sensitive.  This 
observed salt sensitivity indicates that ionic contact(s) are directly involved in the ground 
state binding of DHF.    
 Salt sensitivity of the parameters kcat, kcat/Km (NADPH), and kcat/Km (DHF) for wt R67 
DHFR provides information concerning the role of ionic contacts in formation of the 
transition state as well as catalysis.  Specifically, the observed increase in kcat with 
increasing salt concentration reflects that catalysis is facilitated by the loss of an ionic 
contact(s).  This behavior is also observed in the presence of the alternate cofactor 
NADH, which lacks the 2’phosphate of NADPH.  However, there is a 50-fold reduction 
in kcat/Km (NADH) compared to kcat/Km (NADPH) indicating the 2’phosphate is important for 
formation of the transition state.  This also suggests that the 2’phosphate of NADPH is 
important for ground state binding of NADPH.   
These data support the hypothesis that at least one ionic contact is involved in the 
ground state binding of each ligand.  The identity of the interaction monitored by kcat 
remains unidentified by these studies, although we proposed this was an interaction with 
the pyrophosphate bridge of the cofactor. 
Which Residue(s) in R67 DHFR are Involved in Ionic Contacts? 
To directly examine the hypothesis that K32 is involved in ionic contacts with 
substrate and cofactor as well as formation of the transition state, K32 was substituted by 
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methionine in the R67 DHFR homotetramer using PCR mutagenesis.  Mutagenesis of 
one residue in the homotetramer results in modification at four related sites.  The 
outcome of this substitution resulted in the formation of an inactive dimer.  Thus, a direct 
approach to studying the role of K32 was not possible.  To rule out the possibility of the 
involvement of K33 in these interactions, the only other charged residue near the active 
site, K33 was substituted with the non-polar reside methionine to eliminate its ability to 
form ionic contacts.  Salt effects on both K33M and wt R67 DHFRs were then pursued.  
The similarity of the kinetic behavior of the K33M mutant to that of wt R67 DHFR 
indicates K33 does not participate in ionic contacts with the ligands. 
 To directly address the role of K32 in ionic interactions in R67 DHFR, a four- 
gene copy construct of R67 DHFR that was linked in frame was utilized.  The resulting 
protein from this construct has a molecular weight equal to four times that of a monomer 
of wt R67 DHFR, where each domain of this protein is equivalent to a monomer in the 
R67 DHFR homotetramer.  This protein is called Quad3 (9).  Asymmetric K32 mutations 
were generated in this system. 
 The K32 asymmetric double mutants constructed include K32M: 1+2, K32M: 
1+3, and K32M: 1+4, where domains containing mutations are indicated numerically.  
Thus, each construct contains the same number of mutations but differs only in which 
domains possess the mutations.  K32M: 1+2 and K32M: 1+4 both possess one mutation 
in each half pore.  However, mutations in K32M: 1+2 occur in domains located across 
the pore from one another while mutations in K32M: 1+4 occur in adjacent domains that 
lie at the same interface.  Both of these mutants have minimal effects on Km (NADPH) and 
Km (DHF) compared to Quad3, 4-fold and 1.2-fold, respectively and 2-fold and 1.6-fold, 
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respectively.  The catalytic rate constant, kcat, however is decreased 4-fold and 8-fold, 
respectively by these mutations.  Additionally, salt effects on these mutants reveal that 
while Km (NADPH), Km (DHF), kcat/Km (NADPH), and kcat/Km (DHF) are salt sensitive; kcat is 
mostly insensitive to ionic strength over the range of 0.03 –0.3µ.  Log-log plots of each 
kinetic parameter vs. ionic strength were generated.  When these plots are compared to 
those for wt R67 DHFR, they reveal that the most significant change in slope occurs with 
respect to kcat.  This reduction in kcat compared to Quad3, the minimal effect of salt on 
this parameter, as well as the significant change in slope for the kcat vs. ionic strength 
plots for these mutants compared to wt R67 DHFR, indicates K32 is involved in 
catalysis.  The observed decrease in kcat with these mutants can be explained if these 
mutants effect ground state binding by limiting the options available for an ionic contact 
between a wt K32 and NADPH in one half pore and a wt K32 residue and DHF in the 
other half pore.  Concomitantly, this would decrease the number of possible binding 
modes available to reach the transition state and thereby reduce kcat.   
 The K32M: 1+3 mutant contains two mutated K32 residues in one half of the 
active site pore of R67 DHFR, while the other half of the pore still contains two wild-
type K32 residues.  From the binding scheme devised by Bradrick et al., (10) NADPH 
binding occurs first, followed by DHF.  Thus, NADPH is expected to bind to the wild-
type half pore of this mutant, forcing DHF to bind to the mutant half pore.  However, 
kinetic analysis of this mutant indicates there are large effects on Km (NADPH) and Km (DHF), 
≥ 36-fold and ≥ 49-fold, respectively.  This unexpected elevation in Km (NADPH) may not 
accurately reflect the true Kd of binding and may include other rate constants (8).  This 
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hypothesis can be experimentally assessed using fluorescence quenching to monitor the 
Kd for NADPH.   
The kcat for the K32M: 1+3 mutant is increased ≥ 4.5-fold compared to Quad3.  
An increase in kcat can be explained if the effects of this mutant are compared to the salt 
effects on wt R67 DHFR.  In wt R67 DHFR, there is an increase in kcat with increasing 
salt concentration suggesting that formation of the transition state is facilitated by the loss 
of an ionic interaction.  Similarly, in the K32M: 1+3 mutant, two K32 residues in one 
half of the active site pore are substituted by methionine.  Since DHF binding occurs after 
NADPH, DHF is forced to bind in the mutant half pore in which there is no possibility 
for ionic contact(s) with K32 residues.  While this has large deleterious effects on the 
ground state binding of DHF, it is compensated for by an increase in kcat for this mutant.  
This observed increase in kcat may be a direct result of the elimination of ionic contact(s) 
in this mutant.  Thus, while ionic interactions are important for ground state binding, their 
loss concurrently aids in the formation of the transition state.       
The K32M: 1+3 mutant provides insight into the role of K32 in DHF binding.  
The significant increase in Km (DHF) when both K32 residues in one of the half pore are 
mutated to methionine indicates that K32 has an ionic interaction(s) with DHF.  Yet, 
NMR, crystallography, and docking data suggest that the tail of DHF is mobile.  A 
possible scenario consistent with this data may arise from the formation of a water-
mediated interaction(s) between the two K32 residues in the same half pore and some 
combination of the α and γ-carboxylate groups of DHF (Figure 1).  This type of 
interaction is referred to in the literature as a solvent separated ion pair.  Solvent 
separated ion pairs are clearly seen in small molecules, particularly in crystals, but have  
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Figure 1.  Representation of the top 23 scoring folate conformers predicted by DOCK in 
the active site pore of R67 DHFR.  Green indicates carbon, blue illustrates nitrogen, red 
depicts oxygen, and white indicates hydrogen atoms.  Symmetry related K32 residues are 
illustrated in yellow (3).  (A).  The top scoring folate conformers in the active site pore 
illustrate various potential dockings where one of the carboxylates in the glu tail of folate 
is near K32 in the C subunit (top) while another set of docked folate conformers place the 
glu tail near K32 in the A subunit.  In each conformer, a solvent separated ion pair could 
occur with the symmetry related K32 residue.  (B).  A 90 rotation of the image in panel A 
indicates that folate conformers were predicted to fall into two main groups.  The 
conformers within both groups possess the ability to interact with a K32 residue in the 
same half pore.  The wide range of conformers predicted by DOCK is consistent with 
NMR and crystallographic studies that indicate the DHF tail is mobile in solution.  This 
suggests that the tail may occupy various positions within the active site of R67 DHFR 
and thus may participate in a direct but weak ionic interaction with K32 as well as a 
water mediated interaction(s).    
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also been proposed to occur in DNA binding proteins and catechol O-methyltranferase 
(11-14).  In addition, recent studies of salt effects on the pKa values of histidines in 
staphylococcal nuclease show clear perturbations (15).  From mutational studies as well 
as modified Poisson-Boltzmann calculations, Lee et al. conclude these perturbations arise 
from nearby charge clusters.  Interestingly, a plot of the relationship between interaction 
energy and distance between charged pairs as a function of ionic strength indicates 
charges separated by ~ 5 Å gave an average interaction energy of 0.6 kcal/mol in 0.01 M 
KCl.  Thus, charge-charge interactions can exist at greater than van der Waals contact 
distances, arising from electric fields that display a 1/r distance dependence.  If water 
separates the interacting pairs, a diminished interaction energy can be expected, although 
this may be partially countered by not needing to pay a desolvation penalty (16).  As salt 
concentration increases to 0.1M KCl, the average interaction energy of charge-charge 
pairs separated by ~ 5 Å decreases to 0.4 kca1/mol (15).  In R67 DHFR, the symmetry of 
the half pore may allow the glutamate tail of DHF to be bound in a balanced position, 
halfway between two K32 residues to facilitate an interaction with either the α and/or γ 
carboxylates.  Any diminishing of the electric fields established by the charges by 
increasing salt concentrations may then allow movement of DHF further into the pore so  
that the distance between the C6 of DHF and the C4 of NADPH is reduced.  This 
movement would allow closer contact between the hydride acceptor and donor positions.  
From docking studies, the distance is predicted to be ~ 4.5 Å, however a distance of  
2.6 Å is predicted to actually achieve hydride transfer (17, 18).   
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Based on the results of the K32M double mutants, the following conclusions can 
be drawn concerning the role of K32 in binding and catalysis.  First, K32 forms an ionic 
interaction(s) with DHF in the ground state (potentially mediated by water) as observed 
from the significant increase in the Km (DHF) for the K32M: 1+3 mutant.  Second, K32 is 
involved in catalysis as the removal of one K32 in each half pore, as in the case of the 
K32M: 1+2 and K32M: 1+4 mutants, results in a significant decrease in kcat.  
Alternatively, loss of both K32s in one half-pore (K32M: 1+3) results in a significant 
increase in kcat.    
Insight into the Role of K32 in R67 DHFR: Comparison of Y69F and K32M 
Asymmetric Double Mutants  
 Asymmetric mutants were originally generated to assess the importance of 
individual residues in ligand binding as well as to engineer specificity.  So far, the effects 
of the Q67H (9), Y69F (Lori Stinnett, unpublished) and K32M asymmetric double 
mutant series have been examined.  Comparison of these double mutants lends insight 
into the role of symmetry in the active site pore of R67 DHFR.  Kinetic data from those 
mutants that lie away for the 222 center of symmetry indicate that mutations in domains 1 
and 2 (Y69F: 1+2 and K32M: 1+2) or in domains 1 and 4 (Y69F: 1+4 and K32M: 1+4), 
i.e. one mutation in each half pore, result in minimal effects on binding of NADPH and 
DHF.  This is reflected by small increases in Km values for both of these ligands  
(Table 1).  Therefore, the minimal effect on binding in these mutants suggests that only 
one of each of these residues is necessary for binding cofactor and substrate.     
Differences between the Y69F and K32M series of asymmetric double mutants 
arise when mutational effects on kcat are studied.  Y69F: 1+2 and Y69F: 1+4 result in 
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Table 1.  Kinetic characterization of Quad3, K32M double 
asymmetric mutants, and Y69F double asymmetric mutants in 
MTH, pH 7 at 30°C. 
 Mutant Km (NADPH)  
(µM) 
Km (DHF)  
(µM) 
kcat (s-1) 
Quad3a 4.4 ± 0.4 6.7 ± 0.4 0.8 ± 0.02 
K32M: 1+2 
 
17.1 ± 0.1 6.7 ± 0.1 0.2 ± 0.01 
K32M: 1+3 
 
≥ 160 ≥ 330 ≥ 3.6  
K32M: 1+4 5.4 ± 0.2 10.5 ± 0.3 0.1 ± 0.01 
Y69F: 1+2b 
 
15.1 ± 0.6 17.7 ± 0.8 1.1 ± 0.03 
Y69F: 1+3b 2.9 ± 0.3 20.3 ± 1.5 0.66 ± 0.03 
    
Y69F: 1+4b 13.1 ± 0.6 25.2 ± 1.6 1.7 ± 0.01 
 
 
 
 
 
 
 
 
a(Ref 9)  
b (Lori Stinnett, published and unpublished results) 
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minor increases in kcat, 1.4-fold and 2-fold effects, while K32M: 1+2 and K32M: 1+4 
result in 4-fold and 8-fold decreases in kcat (Table 1).  Thus, K32 plays a larger role in 
catalysis than Y69.  Further, the decrease in kcat as well as its lowered sensitivity to salt 
concentration, for the K32M: 1+2 and K32M: 1 +4 mutants as compared to wt R67 
DHFR, illustrates these mutants may affect formation of the transition state. As 
mentioned previously, this situation could arise due to these mutants possessing only one 
K32 capable of participating in an ionic interaction in each half pore.  Thus, these 
mutants may impose a constraint on formation of the ground state as the ligands are 
forced to interact with the remaining K32 residue in each half pore.  Concurrently, the 
number of possible binding modes is reduced.  As a result, the number of species 
available to form the transition state would decrease giving rise to fewer available species 
to participate in catalysis.  Thus, kcat would be lower than that of Quad3.  This is 
consistent with the observed decrease in kcat for the K32M: 1+2 and K32M: 1+4 mutants.  
In contrast, the K32M: 1+3 mutant, which contains both mutations in one half pore, 
results in a ≥ 36 fold elevation in Km (NADPH), a ≥ 49 fold elevation in Km (DHF), as well as a 
≥ 4.5 fold increase in kcat compared to Quad3.  The significant increase in Km (DHF) for this  
mutant suggests that K32 participates in an ionic contact(s) with DHF that appears 
important for ground state binding.  Alternatively, the higher kcat value observed for this 
mutant, which lacks the ability to participate in ionic contacts with DHF compared to 
Quad3, indicates that these ionic contacts impede formation of the transition state in wt 
R67 DHFR.  
Together, these data suggest that R67 DHFR uses symmetry to facilitate catalysis 
by providing equivalent binding sites in the active site pore.  Furthermore, breaking the 
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symmetry only leads to a scenario that partially mimics the salt effect when both K32 
residues are removed from one half of the pore.  This suggests R67 DHFR uses its 
symmetry to produce a binding mode for DHF that is balanced between the K32 residues.  
When the glutamate tail of DHF is “pushed” or “pulled” to the two binding extremes in 
the K32M: 1+2 and K32M: 1+4 double mutants, the catalytic rate suffers.            
General Models for K32’s Participation in Ionic Interactions with NADPH and DHF 
Several models can be generated to describe a role for K32 in ionic interactions in 
wt R67 DHFR.  (1) As proposed in part II, two K32 residues may participate in ionic 
interactions with NADPH.  This model is refuted by the results from part III, where 
effects of a single K32M mutation in each half pore, as seen in the K32M: 1+2 and 
K32M: 1+4 mutants, are minimal.  In addition, there is not a significant change in the 
slopes of log-log plots of kcat/Km (NADPH) vs. ionic strength for these mutants compared to 
wt R67 DHFR.  (2) One K32 residue and a cluster of charged residues on the surface of 
R67 DHFR may participate in ionic interactions with cofactor and substrate.  
Electrostatic potential predictions by the computational algorithm DELPHI, a finite 
Poisson-Boltzmann difference solver, predict that wt R67 DHFR possesses a positive 
electrostatic potential at the active site pore (Figure 2).  This electrostatic potential may 
facilitate binding of NADPH and DHF.  Generation of the asymmetric K32M double 
mutants is predicted to reduce the positive electrostatic potential at the active site, 
particularly in the case of the K32M: 1+3 mutant, which possesses 2 mutations in the 
same half pore (Figure 2).  Additionally, the surface of R67 DHFR possesses a group of 
charged residues that are conserved including R31, E75, R29, and E60.  This charged 
cluster might also play a role in cofactor and substrate binding.  The importance of  
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Figure 2.  Electrostatic potential predictions of K32M asymmetric double mutants 
generated using DELPHI, a finite Poisson-Boltzmann difference solver (3).  Blue depicts 
areas of positive electrostatic potential, red illustrates regions of negative electrostatic 
potential, and white depicts areas of neutral potential. (A).  The predicted electrostatic 
potential for wt R67 DHFR indicates the active site pore possesses a positive electrostatic 
potential generated mostly by symmetry related K32 residues.  (B) The electrostatic 
potential prediction for the K32M: 1+2 mutant indicates that substituting 2 K32 residues 
with methionine at opposite ends of the pore (diagonally) reduces the positive 
electrostatic potential at each end.  (C). The electrostatic potential prediction for the 
K32M: 1+4 mutant is quite similar to that from panel B, as substituting 2 K32 residues, 
each at opposite ends of the pore, reduces the positive electrostatic potential at each end.  
(D).  The K32M: 1+3 mutant possesses a diminished positive electrostatic potential at the 
active site pore due to the substitution of 2 K32 residues in the same half pore.  Here the 
potential at the end facing the viewer is greatly diminished.    
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clusters of charged residues in enzyme structure and function has been recently been 
documented (19).  (3) A third model includes at least one ionic contact between K32 and 
NADPH as well as K32 and DHF in the ground state.  However, to reach the transition 
state, an ionic interaction is lost, most likely one between DHF and K32.  This model 
seems most likely from the data generated to date.  The lack of significant effects on the 
Km values for NADPH and DHF in the K32M asymmetric double mutants K32M: 1+2 
and K32M: 1+4, the reduction in kcat for these mutants, a minimal salt effect on  
kcat/Km (NADH), as well as a significant effect on DHF binding with the K32M: 1+3 
mutant, support that there is at least one ionic interaction in the ground state with each 
ligand.  Additionally, support for the loss of an ionic interaction in the transition state 
comes from the observed increase in kcat in the presence of increasing ionic strength for 
the K32M: 1+3 mutant and wt R67 DHFR, the salt sensitivity of kcat/Km (NADPH) and 
kcat/Km (DHF) for wt R67 DHFR, and the increase in kcat with increasing ionic strength in 
the presence of the alternate cofactor NADH.      
Model for Electrostatics in the Catalytic Mechanism of R67 DHFR 
The data presented herein can be used to generate a general model describing the 
total contribution of both the electrostatic potential and ionic interactions to the catalytic 
mechanism of R67 DHFR.  The positive electrostatic potential at the active site pore of 
R67 DHFR attracts both NADPH and DHF.  This facilitates binding of NADPH to the ε-
amine group of K32 through the oxygen atoms of the 2’phosphate and/or the oxygen 
atoms of the pyrophosphate bridge.  DHF binding then occurs, facilitated by the 
attraction of the positive electrostatic potential, and the α, γ, or some combination of 
these carboxylate groups in the glutamate tail of DHF form an ionic contact(s), such as a 
145  
water-mediated ionic contact, with K32 (Figure 1).  This facilitates binding in an 
orientation such that there is some overlap of the nicotinamide ring of NADPH and the 
pteridine ring of DHF.  Formation of the endo transition state is then achieved, which has 
been suggested to be more favorable for R67 DHFR than the exo transition state (20).  In 
the endo transition state, the nicotinamide ring of NADPH and the pteridine ring of DHF 
are stacked on one another resulting in the hydride on the C4 of the donating 
nicotinamide ring being in close proximity to the accepting C6 of DHF.  Hydride transfer, 
the rate-limiting step, then occurs and the product, tetrahydrofolate, is released as well as 
NADP+.   
Summary and Conclusions 
This research has provided insight into the role of K32 in the catalytic mechanism 
of R67 DHFR.  The overall approach used by R67 DHFR to facilitate catalysis involves a 
symmetrical active site, which provides equivalent binding sites.  Equivalent binding 
sites appear to be especially crucial with respect to ionic interactions in the ground state.  
Reducing the number of available sites for ionic contacts in the ground state results in a 
decrease in kcat.  This most likely arises from a reduction in the number of species able to 
adopt the transition state.  On the other hand, ionic interactions seem to impose a 
constraint on formation of the transition state, as complete elimination of these 
interactions at least with respect to DHF, results in an increase in kcat.  Thus, there is a 
fine balance between the symmetry of the active site pore, which is used to facilitate ionic 
contacts for ground state binding, with the rate of product formation, which seems limited 
by ionic contacts.     
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